publication_id,tool,quote,best_match_source,best_match,similarity
1528,PRECIS-2,"The main analysis evaluated the total costs of the intervention, resource use and medication at eight months after randomization.",fulltext,"The main analysis evaluated the total costs of the intervention, resource use and medication at eight months after randomization.",100.0
1528,PRECIS-2,"Participants were included who scored >2 on the General Health Questionnaire 12, a measure of psychological distress, or >7 on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale, thus confirming they had low mood.",fulltext,"participants were included who scored >2 on the General Health Questionnaire 12,7 a measure of psychological distress, or >7 on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale,8 thus confirming they had low mood.",100.0
1528,PRECIS-2,Community.,fulltext,Community.,100.0
1528,PRECIS-2,Participants randomly allocated to the adjustment group received six group treatment sessions.,fulltext,Participants randomly allocated to the adjustment group received six group treatment sessions.,100.0
1528,PRECIS-2,Participants allocated to intervention were invited to attend a psychological adjustment group for six sessions over 12 weeks.,fulltext,se allocated to intervention were invited to attend a psychological adjustment group for six sessions over 12 weeks.,91.26984126984127
1528,PRECIS-2,"People with multiple sclerosis were screened on the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and those with low mood were recruited.",fulltext,"People with multiple sclerosis were screened on the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and those with low mood were recruited.",100.0
1528,PRECIS-2,The aim of the present study was to determine the cost effectiveness of the intervention.,fulltext,The aim of the present study was to determine the cost effectiveness of the intervention.,100.0
1528,PRECIS-2,"Outcomes were assessed four and eight months after randomization, blind to group allocation.",fulltext,"Outcomes were assessed four and eight months after randomization, blind to group allocation.",100.0
1528,PRECIS-2,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",fulltext,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",100.0
1529,PRECIS-2,This clinical trial was conducted in 2015–2016 and registered as IRCT2014112420064N1 in the Iranian Register of Clinical Trials. The study population consists the patients referring to the Multiple Sclerosis Society of Isfahan.,fulltext,This clinical trial was conducted in 2015–2016 and registered as IRCT2014112420064N1 in the Iranian Register of Clinical Trials. The study population consists the patients referring to the Multiple Sclerosis Society of Isfahan.,100.0
1529,PRECIS-2,"The intervention was implemented within two days a week. For the control group, a routine protocol was conducted.",fulltext,"The intervention was implemented within two days a week. For the control group, a routine protocol was conducted.",100.0
1529,PRECIS-2,"This study demonstrated a significant difference in levels of stress, depression, and total fatigue between before and after the intervention, representing the optimal effect of FHM in decreasing the severity of stress, depression, and total fatigue. Regarding anxiety, however, the difference in the mean score was not significant between before and after the intervention.",fulltext,"This study demonstrated a significant difference in levels of stress, depression, and total fatigue between before and after the intervention, representing the optimal effect of FHM in decreasing the severity of stress, depression, and total fatigue. Regarding anxiety, however, the difference in the mean score was not significant between before and after the intervention.",100.0
1529,PRECIS-2,"Because the patients were not hospitalized and regularly referred to the Association, to follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants.",fulltext,"Because the patients were not hospitalized and regularly referred to the Association, to follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants.",100.0
1529,PRECIS-2,"At completion of the training program, all happy techniques were briefly reviewed with the participants, the participants were asked some questions about their current happiness and optimism levels, and their questions, if any, were answered. Then, DASS-21 and Piper Scale were administered to the participants.",fulltext,"At completion of the training program, all happy techniques were briefly reviewed with the participants, the participants were asked some questions about their current happiness and optimism levels, and their questions, if any, were answered. Then, DASS-21 and Piper Scale were administered to the participants.",100.0
1529,PRECIS-2,"The data obtained before and after conduction of the program were analyzed by chi-square test, Mann-Whitney, covariance statistics, repeated measures ANOVA, and independent t-test in SPSS 18.",fulltext,"The data obtained before and after conduction of the program were analyzed by chi-square test, Mann-Whitney, covariance statistics, repeated measures ANOVA, and independent t-test in SPSS 18.",100.0
1529,PRECIS-2,"The participants were acknowledged for their participation in the study and the follow-up session was decided to be held three months later. Moreover, to investigate the efficacy of the FHM, the DASS-21 and Piper Standard Scale were administered to the experimental group in the follow-up session.",fulltext,"The participants were acknowledged for their participation in the study and the follow-up session was decided to be held three months later. Moreover, to investigate the efficacy of the FHM, the DASS-21 and Piper Standard Scale were administered to the experimental group in the follow-up session.",100.0
1529,PRECIS-2,"The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.",fulltext,"The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.",100.0
1529,PRECIS-2,"The intervention consisted of: defining depression, stress, anxiety, and their symptoms, defining happiness, and explaining its necessity, reviewing the results of previous studies on happiness (the first session); the technique of increasing physical activity, the technique of being productive, and doing useful and meaningful things (the second session); the principles of planning and better organization--the technique of removing concerns, the technique of reducing expectations and wishes (the third session); the technique of enhancing creativity, the technique of living at present (the fourth session; the technique of increasing social relationships, the technique of being the real self (the fifth session).",fulltext,"The intervention consisted of: defining depression, stress, anxiety, and their symptoms, defining happiness, and explaining its necessity, reviewing the results of previous studies on happiness (the first session); the technique of increasing physical activity, the technique of being productive, and doing useful and meaningful things (the second session); the principles of planning and better organization--the technique of removing concerns, the technique of reducing expectations and wishes (the third session); the technique of enhancing creativity, the technique of living at present (the fourth session; the technique of increasing social relationships, the technique of being the real self (the fifth session).",100.0
1567,PRECIS-2,"The comparison group received their usual care and a referral to 'MyBrainGames', available for free at MultipleScerosis.com.",fulltext,"The comparison group received their usual care and a referral to 'MyBrainGames', available for free at MultipleScerosis.com.",100.0
1567,PRECIS-2,The purpose of this study was to test the refined MAPSS-MS intervention in a larger multi-site trial with a six-month follow-up.,fulltext,The purpose of this study was to test the refined MAPSS-MS intervention in a larger multi-site trial with a six-month follow-up.,100.0
1567,PRECIS-2,"The majority of participants were female (87%), white (75%), and married (64%).",fulltext,"The majority of participants were female (87%), white (75%), and married (64%).",100.0
1567,PRECIS-2,"The intervention included eight weekly 2-h group sessions focused on building efficacy for use of cognitive compensatory strategies and lifestyle activities that support cognitive functioning (e.g., sleep and rest, exercise) paired with a home-based computer-assisted cognitive training program.",fulltext,"The intervention included eight weekly 2-h group sessions focused on building efficacy for use of cognitive compensatory strategies and lifestyle activities that support cognitive functioning (e.g., sleep and rest, exercise) paired with a home-based computer-assisted cognitive training program.",100.0
1567,PRECIS-2,The fact that both groups demonstrated improvements over time underscores the importance that many people with MS place on dealing with their cognitive limitations.,fulltext,The fact that both groups demonstrated improvements over time underscores the importance that many people with MS place on dealing with their cognitive limitations.,100.0
1567,PRECIS-2,"The effects of the intervention on outcomes were assessed over an 8-month period, with measurements at baseline, immediately after the 8-week MAPPS intervention, and at 3 and 6 months post-intervention.",fulltext,"The effects of the intervention on outcomes were assessed over an 8-month period, with measurements at baseline, immediately after the 8-week MAPPS intervention, and at 3 and 6 months post-intervention.",100.0
1567,PRECIS-2,"The primary purpose of this study was to determine the effectiveness of a novel computer-assisted cognitive rehabilitation intervention MAPSS-MS (Memory, Attention, Problem Solving Skills in MS) in a multi-site trial with persons with MS.",fulltext,"The primary purpose of this study was to determine the effectiveness of a novel computer-assisted cognitive rehabilitation intervention MAPSS-MS (Memory, Attention, Problem Solving Skills in MS) in a multi-site trial with persons with MS.",100.0
1567,PRECIS-2,Persons with MS (N = 183) with cognitive concerns were randomly assigned to either the 8-week MAPSS-MS intervention or usual care plus freely available computer games.,fulltext,Persons with MS (N = 183) with cognitive concerns were randomly assigned to either the 8-week MAPSS-MS intervention or usual care plus freely available computer games.,100.0
1567,PRECIS-2,The MAPSS-MS intervention aims to help persons with MS acquire the highest level of cognitive functioning and functional independence.,fulltext,The MAPSS-MS intervention aims to help persons with MS acquire the highest level of cognitive functioning and functional independence.,100.0
1567,PRECIS-2,"Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",fulltext,"Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",100.0
1567,PRECIS-2,"Changes in study outcomes were analyzed using intention to treat methodology, ANOVA with repeated measures, and ANCOVA.",fulltext,"Changes in study outcomes were analyzed using intention to treat methodology, ANOVA with repeated measures, and ANCOVA.",100.0
1567,PRECIS-2,"Participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas.",fulltext,"Participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas.",100.0
1568,PRECIS-2,"A Poisson regression controlling for a priori defined potential confounding variables (age, gender and time since diagnosis) and expressed as an incidence-rate-ratio was applied to compare the annual relapse rate between the RCT groups.",fulltext,"A Poisson regression controlling for a priori defined potential confounding variables (age, gender and time since diagnosis) and expressed as an incidence-rate-ratio was applied to compare the annual relapse rate between the RCT groups.",100.0
1568,PRECIS-2,The relapse rate and the global brain atrophy rate were the primary outcomes of this study.,fulltext,The relapse rate and the global brain atrophy rate were the primary outcomes of this study.,100.0
1568,PRECIS-2,"Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society. Inclusion criteria were (1) 18–60  years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",fulltext,"Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society. Inclusion criteria were (1) 18–60  years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",100.0
1568,PRECIS-2,Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.,fulltext,Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.,100.0
1568,PRECIS-2,"The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles (adapted from Stathopoulos and Felson Duchan)13: (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.",fulltext,"The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles (adapted from Stathopoulos and Felson Duchan)13: (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.",100.0
1568,PRECIS-2,"The study period covers 48 weeks with outcome assessment at baseline (T0), after 24 weeks (T24), and after 48 weeks (T48).",fulltext,"The study period covers 48 weeks with outcome assessment at baseline (T0), after 24 weeks (T24), and after 48 weeks (T48).",100.0
1568,PRECIS-2,The present study is a national multicentre single-blinded parallel group randomized controlled trial (RCT) comparing two groups receiving either supervised exercise therapy (intervention group) or health education (active control group).,fulltext,The present study is a national multicentre single-blinded parallel group randomized controlled trial (RCT) comparing two groups receiving either supervised exercise therapy (intervention group) or health education (active control group).,100.0
1568,PRECIS-2,"Patients in the supervised exercise group completed 90.0 (8.6)% of the planned sessions at an average intensity of 84.4 (3.0)% HRmax (for comparison, the planned average intensity was 76.2% HRmax).",fulltext,"Patients in the supervised exercise group completed 90.0 (8.6)% of the planned sessions at an average intensity of 84.4 (3.0)% HRmax (for comparison, the planned average intensity was 76.2% HRmax).",100.0
1569,PRECIS-2,"The 12-weeks follow-up after TOCT was collected in the entire population (n = 36), confirming how the positive effects on the primary outcome measure, the 6MWT, were maintained after the end of treatment (p<0.001).",fulltext,"The 12-weeks follow-up after TOCT was collected in the entire population (n = 36), confirming how the positive effects on the primary outcome measure, the 6MWT, were maintained after the end of treatment (p<0.001).",100.0
1569,PRECIS-2,"An intention-to-treat analysis was carried out on all outcome measures, handling missing data (n = 2 at T1, n = 7 at T2) with the last observation carried forward approach.",fulltext,"An intention-to-treat analysis was carried out on all outcome measures, handling missing data (n = 2 at T1, n = 7 at T2) with the last observation carried forward approach.",100.0
1569,PRECIS-2,"At home, we recommended 60-minute sessions three times/week. The home-based program includes overground walking practice and exercises with similar modalities and difficulty as learnt during Phase 1.",fulltext,"At home, we recommended 60-minute sessions three times/week. The home-based program includes overground walking practice and exercises with similar modalities and difficulty as learnt during Phase 1.",100.0
1569,PRECIS-2,"The inclusion criteria were: males and females; age 18 to 70; diagnosis of MS (primary or secondary progressive, relapsing-remitting), without relapses in the preceding three months and an Expanded Disability Status Scale (EDSS) score between 4 and 5.5.",fulltext,"The inclusion criteria were: males and females; age 18 to 70; diagnosis of MS (primary or secondary progressive, relapsing-remitting), without relapses in the preceding three months and an Expanded Disability Status Scale (EDSS) score between 4 and 5.5.",100.0
1569,PRECIS-2,36 PwMS with EDSS 4–5.5 and unassisted walking have been randomly assigned,fulltext,36 PwMS with EDSS 4–5.5 and unassisted walking have been randomly assigned,100.0
1569,PRECIS-2,"The blind evaluator, who did not supervise the training program, performed functional tests, questionnaires and instrumental measurements",fulltext,"The blind evaluator, who did not supervise the training program, performed functional tests, questionnaires and instrumental measurements",100.0
1569,PRECIS-2,"TOCT includes six workstations with five levels of complexity (step, slalom, tandem exercise, goals, obstacles, long step).",fulltext,"TOCT includes six workstations with five levels of complexity (step, slalom, tandem exercise, goals, obstacles, long step).",100.0
1569,PRECIS-2,Retention was tested on the whole sample at a 12-weeks follow-up.,fulltext,Retention was tested on the whole sample at a 12-weeks follow-up.,100.0
1569,PRECIS-2,"A superiority of task-oriented program was verified for 6MWT (F, 2,88 = 7.80; p<0.001) on usual care after the 12-weeks home-based program.",fulltext,"A superiority of task-oriented program was verified for 6MWT (F, 2,88 = 7.80; p<0.001) on usual care after the 12-weeks home-based program.",100.0
1569,PRECIS-2,Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.,fulltext,Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.,100.0
1569,PRECIS-2,"The exclusion criteria were: other conditions that may affect motor function, impaired cognitive functioning that interferes with the acquisition of the consent to the study.",fulltext,"The exclusion criteria were: other conditions that may affect motor function, impaired cognitive functioning that interferes with the acquisition of the consent to the study.",100.0
1570,PRECIS-2,"The study was conducted at Farshchian Hospital in Hamadan, Iran.",fulltext,"ethods The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (Wes",84.375
1570,PRECIS-2,"The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 2005- 2006, who had the following criteria: Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI according to McDonald’s criteria, acceptance of the 24 month protocol by the patients, not being pregnant or lactating, history of having received a kind of β- interferon under the supervision of a neurologist in a period of no more than 30 days prior to the study.",fulltext,"The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 2005- 2006, who had the following criteria: Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI according to McDonald’s criteria, acceptance of the 24 month protocol by the patients, not being pregnant or lactating, history of having received a kind of β- interferon under the supervision of a neurologist in a period of no more than 30 days prior to the study.",100.0
1570,PRECIS-2,"We aimed to compare the therapeutic effect of Avonex (Av), Betaferon (Be) & Rebif (Re) on the Expanded Disability Status Scale (EDSS) in Multiple Sclerosis (MS).",fulltext,"We aimed to compare the therapeutic effect of Avonex (Av), Betaferon (Be) & Rebif (Re) on the Expanded Disability Status Scale (EDSS) in Multiple Sclerosis (MS).",100.0
1570,PRECIS-2,"Comparative study of the average First and Final EDSS, using the paired sample t.test, showed a significant statistical difference in all three groups.",fulltext,"Comparative study of the average First and Final EDSS, using the paired sample t.test, showed a significant statistical difference in all three groups.",100.0
1570,PRECIS-2,"Treatment with all forms of β- interferons is accompanied with mild, moderate and severe side effects.",fulltext,"Treatment with all forms of β- interferons is accompanied with mild, moderate and severe side effects.",100.0
1570,PRECIS-2,"The patients in all three groups were evaluated at the end of months 6, 12, 18, 24 and in case of development of reactions were excluded from the study.",fulltext,"The patients in all three groups were evaluated at the end of months 6, 12, 18, 24 and in case of development of reactions were excluded from the study.",100.0
1570,PRECIS-2,"Each of these drugs have a significant effect in reducing the relapse rate, progression of disease and MRI findings though none of them has a positive effect on PPMS.",fulltext,"Each of these drugs have a significant effect in reducing the relapse rate, progression of disease and MRI findings though none of them has a positive effect on PPMS.",100.0
1570,PRECIS-2,"Exclusion criteria were as follows: 1) history of malignancy within the past five years 2) history of HIV infection, positive serology for hepatitis B and C 3) history of infectious disease within six weeks prior to the study and need for hospitalization from an infectious cause within two months prior to the study 4) any kind of hematological abnormality such as lymphocyte count ≤ 1 x 109/ L , platelet count ≤ 100 x 109/ L , neutrophil count ≤ 1.5 x 109/ L ,and hemoglobin level ≤ 8.5 g/dl 5)any kind of definite functional abnormality in body organs that disables the patient for treatment with β- interferons(criteria for functional abnormality in such cases included:creatinin ≥ 1.6 mg/dl , AST or ALT ≥ 2.5 x maximum normal values , alkaline phosphatase ≥2.5 x maximum normal values ,and history of heart failure, myocardial infarction or arrhythmia within six months prior to the study) 6)vaccination using live virus vaccines within four weeks prior to the study 7) use of antimetabolites or cytotoxic drugs within six months prior to the study 8) patients with PPMS 9)any kind of elective surgery during the study 10)rise in hepatic enzymes or severe drug reactions during the follow up period.",fulltext,"Exclusion criteria were as follows: 1) history of malignancy within the past five years 2) history of HIV infection, positive serology for hepatitis B and C 3) history of infectious disease within six weeks prior to the study and need for hospitalization from an infectious cause within two months prior to the study 4) any kind of hematological abnormality such as lymphocyte count ≤ 1 x 109/ L , platelet count ≤ 100 x 109/ L , neutrophil count ≤ 1.5 x 109/ L ,and hemoglobin level ≤ 8.5 g/dl 5)any kind of definite functional abnormality in body organs that disables the patient for treatment with β- interferons(criteria for functional abnormality in such cases included:creatinin ≥ 1.6 mg/dl , AST or ALT ≥ 2.5 x maximum normal values , alkaline phosphatase ≥2.5 x maximum normal values ,and history of heart failure, myocardial infarction or arrhythmia within six months prior to the study) 6)vaccination using live virus vaccines within four weeks prior to the study 7) use of antimetabolites or cytotoxic drugs within six months prior to the study 8) patients with PPMS 9)any kind of elective surgery during the study 10)rise in hepatic enzymes or severe drug reactions during the follow up period.",100.0
1769,PRECIS-2,only patients who could walk with or without walking aids were admitted to the trial,fulltext,only patients who could walk with or without walking aids were admitted to the trial,100.0
1769,PRECIS-2,The dose of corticotrophin was adjusted to produce just enough 'mooning' of the face to be appreciated by the physician in charge of the trial,fulltext,"The dose of corticotrophin was adjusted to produce just enough "" mooning "" of the face to be appreciated by the physician in charge of the trial",100.0
1769,PRECIS-2,Patients with multiple sclerosis were randomly selected into treated and control groups,fulltext,Patients with multiple sclerosis were randomly selected into treated and control groups,100.0
1769,PRECIS-2,Patients with diabetes mellitus or hypertension or who gave a history of psychiatric illness or peptic ulcer were not admitted to the treated group,fulltext,Patients with diabetes mellitus or hypertension or who gave a history of psychiatric illness or peptic ulcer were not admitted to the treated group,100.0
1769,PRECIS-2,It could not be a double-blind study,fulltext,It could not be a doubleblind study,97.22222222222221
1769,PRECIS-2,There is no evidence that treatment prevented deterioration or reduced the number or severity of the relapses,fulltext,There was no evidence that treatment prevented deterioration or reduced the number or severity of the relapses,99.08256880733946
1769,PRECIS-2,All cases were seen at three-monthly intervals and scored on the Kurtzke scale,fulltext,All cases were seen at three-monthly intervals and scored on the Kurtzke (1961) scale,100.0
1769,PRECIS-2,"The total results were obtained by adding the results from the three cities; this was considered justifiable since the methods of selection, treatment, and scoring were essentially the same",fulltext,"The total results were obtained by adding the results from the three cities; this was considered justifiable since the methods of selection, treatment, and scoring were essentially the same",100.0
1769,PRECIS-2,"This controlled study was started in 1963 in three cities- Belfast, Leeds, and Manchester",fulltext,"This controlled study was started in 1963 in three cities- Belfast, Leeds, and Manchester",100.0
1769,PRECIS-2,Nearly all patients treated with corticotrophin showed a slight rise in blood-pressure and a gain in weight,fulltext,Nearly all patients treated with corticotrophin showed a slight rise in blood-pressure and a gain in weight,100.0
1769,PRECIS-2,Both treated and control groups were given aneurin 100 mg. by injection monthly,fulltext,Both treated and control groups were given aneurin 100 mg. by injection monthly,100.0
1769,PRECIS-2,The dose was not increased during a relapse,fulltext,The dose was not increased during a relapse,100.0
1769,PRECIS-2,Relapses lasting longer than twenty-four hours were also scored by a system in the three centres,fulltext,Relapses lasting longer than twenty-four hours were also scored by a system in the three centres,100.0
1770,PRECIS-2,"Only 29 patients entered the trial. The number of patients was much smaller than was hoped for when the study was envisaged. This was due to a changing attitude towards bed rest and the introduction of short term high dose methylprednisolone treatment, which rapidly has gained a wide acceptance among neurologists.",fulltext,"Only 29 patients entered the trial. The number of patients was much smaller than was hoped for when the study was envisaged. This was due to a changing attitude towards bed rest and the introduction of short term high dose methylprednisolone treatment (9), which rapidly has gained a wide acceptance among neurologists.",100.0
1770,PRECIS-2,"Follow-up was performed in the 6th and 12th week of treatment and 6, 9, and 12 months after the start of treatment.",fulltext,"Follow-up was performed in the 6th and 12th week of treatment and 6, 9, and 12 months after the start of treatment.",100.0
1770,PRECIS-2,"Mann-Whitney U tests revealed a statistically significant greater improvement in the ACTH group in the brain stem and sensory FS, the ISS and in the Ambulation Index, but at 6 months none of these significant differences were still present.",fulltext,"MannWhitney U tests revealed a statistically significant greater improvementin the ACTH group in the brain stem and sensory FS, the ISS and in the Ambulation Index, but at 6 months none of these significant differences were still present.",99.16666666666667
1770,PRECIS-2,There were no statistically significant differences between both patient groups at the start of treatment.,fulltext,There were no statistically significant differences between both patient groups at the start of treatment.,100.0
1770,PRECIS-2,"Patients with contraindications to bed rest or ACTH-treatment, such as hypersensitivity to ACTH, acute infections, cardial insufficiency, psychosis, pregnancy, Cushing syndrome or peptic ulcer, were excluded.",fulltext,"Patients with contraindications to bed rest or ACTH-treatment, such as hypersensitivity to ACTH, acute infections, cardial insufficiency, psychosis, pregnancy, Cushing syndrome or peptic ulcer, were excluded.",100.0
1770,PRECIS-2,"Only patients with a clinical or laboratory-supported definite diagnosis of MS according to the Poser criteria, suffering from a relapse, were included.",fulltext,"Only patients with a clinical or laboraton- supported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse, were included.",98.68421052631578
1770,PRECIS-2,Our results showed a greater improvement in some symptoms of relapse in MS patients after 6 or more weeks in the ACTH-treated patients. This difference did not outlast 6 months in any respect.,fulltext,Our results showed a greater improvement in some symptoms of relapse in MS patients after 6 or more weeks in the ACTH-treated patients. This difference did not outlast 6 months in any respect.,100.0
1770,PRECIS-2,Three neurological departments in the Netherlands participated in this study.,fulltext,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",100.0
1770,PRECIS-2,"Side effects, like a mild raise of blood pressure, mild diabetes mellitus, Cushing face, mood alterations, urinary tract infection, were significantly more often seen in the ACTH group.",fulltext,"Side effects, like a mild raise of bloodpressure. mild diabetes mellitus, Cushing face, mood alterations, urinary tract infection, were significantly more often seen in the ACTH group.",99.45945945945947
1771,PRECIS-2,"The PAE intervention was well tolerated, with no serious adverse events",fulltext,"The PAE intervention was well tolerated, with no serious adverse events",100.0
1771,PRECIS-2,The PAE group underwent supervised high-intensity PAE for 24 weeks,fulltext,The PAE group underwent supervised high-intensity PAE for 24 weeks,100.0
1771,PRECIS-2,"Follow-up data at T48 showed broad beneficial within-group effects in the PAE group, potentially caused by learning effects or a long-lasting, but slow, prophylactic effect that continued throughout follow-up",fulltext,"Follow-up data at T48 showed broad beneficial within-group effects in the PAE group, potentially caused by learning effects or a long-lasting, but slow, prophylactic effect that continued throughout follow-up",100.0
1771,PRECIS-2,Twelve pwMS were unable to adhere with the prescribed intensity of 90%–95% of HRmax during the last 8 weeks of the intervention,fulltext,Twelve pwMS were unable to adhere with the prescribed intensity of 90%–95% of HRmax during the last 8 weeks of the intervention,100.0
1771,PRECIS-2,Eighty-six participants were recruited from Danish MS clinics,fulltext,Eighty-six participants were recruited from Danish MS clinics,100.0
1771,PRECIS-2,The session volume increased from 30 to 60 minutes during the intervention while the intensity increased from 65% to 95% of individual maximum heart rate,fulltext,The session volume increased from 30 to 60 minutes during the intervention while the intensity increased from 65% to 95% of individual maximum heart rate,100.0
1771,PRECIS-2,"Exercise adherence was high with 44.8 ± 2.6 completed sessions, corresponding to 93.3 ± 5.4% of the planned sessions",fulltext,"Exercise adherence was high with 44.8 ± 2.6 completed sessions, corresponding to 93.3 ± 5.4% of the planned sessions",100.0
1771,PRECIS-2,"Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week",fulltext,"Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week",100.0
1771,PRECIS-2,"Results at T48 showed that after 24 weeks of self-guided physical exercise, the improvements in cardiorespiratory fitness following PAE disappeared",fulltext,"Results at T48 showed that after 24 weeks of self-guided physical exercise, the improvements in cardiorespiratory fitness following PAE disappeared",100.0
1771,PRECIS-2,"The PAE group underwent supervised high-intensity PAE for 24 weeks, while the waitlist group continued their habitual lifestyle without commencing PAE",fulltext,"The PAE group underwent supervised high-intensity PAE for 24 weeks, while the waitlist group continued their habitual lifestyle (including ongoing physiotherapy treatment) without commencing PAE",100.0
1771,PRECIS-2,"For inclusion and exclusion criteria, see Langeskov-Christensen et al.24",fulltext,"For inclusion and exclusion criteria, see Langeskov-Christensen et al.24",100.0
1771,PRECIS-2,The waitlist group continued their habitual lifestyle without commencing PAE,fulltext,the waitlist group continued their habitual lifestyle (including ongoing physiotherapy treatment) without commencing PAE,100.0
1771,PRECIS-2,All longitudinal data for the total group and the cognitively impaired subgroup were analyzed using an intention-to-treat linear mixed effects model with time and group as the factors of interest,fulltext,All longitudinal data for the total group and the cognitively impaired subgroup were analyzed using an intention-to-treat linear mixed effects model with time and group as the factors of interest,100.0
1771,PRECIS-2,"The potential effects of PAE were analyzed in both the total group and in the subgroup showing mild to moderate cognitive impairment, using a validated battery of neuropsychological tests",fulltext,"The potential effects of PAE were analyzed in both the total group and in the subgroup showing mild to moderate cognitive impairment, using a validated battery of neuropsychological tests",100.0
1771,PRECIS-2,Participants were recruited from Danish MS clinics,fulltext,Participants were recruited from Danish MS clinics,100.0
1771,PRECIS-2,"Based on the Z-scores, 37 pwMS (43%) were classified as cognitively impaired",fulltext,"Based on the Z-scores, 37 pwMS (43%) were classified as cognitively impaired",100.0
1772,PRECIS-2,"EPOC was a 6-month, randomized, open-label, multicenter, phase 4 study conducted in the USA and Canada.",fulltext,"EPOC was a 6-month, randomized, open-label, multicenter, phase 4 study conducted in the USA and Canada.",100.0
1772,PRECIS-2,"Patients randomized to the iDMT group either remained on the same therapy or, following consultation with a physician, were switched immediately to another approved iDMT.",fulltext,"Patients randomized to the iDMT group either remained on the same therapy or, following consultation with a physician, were switched immediately to another approved iDMT.",100.0
1772,PRECIS-2,"Men and women aged 18–65 years with relapsing forms of MS, as defined by the 2005 revised McDonald criteria [14], and an Expanded Disability Status Scale (EDSS) score of 0–5.5 were eligible to participate in the study.",fulltext,"Men and women aged 18–65 years with relapsing forms of MS, as defined by the 2005 revised McDonald criteria [14], and an Expanded Disability Status Scale (EDSS) score of 0–5.5 were eligible to participate in the study.",100.0
1772,PRECIS-2,"Post hoc analyses were conducted using SAS software v9.2 (SAS, Cary, NC, USA). For the analysis of individual iDMTs, the primary variable was assessed using analysis of covariance, with baseline TSQM Global Satisfaction score as a covariate and treatment group as a main effect, as was done for the analysis of the pooled iDMTs [13].",fulltext,"Post hoc analyses were conducted using SAS software v9.2 (SAS, Cary, NC, USA). For the analysis of individual iDMTs, the primary variable was assessed using analysis of covariance, with baseline TSQM Global Satisfaction score as a covariate and treatment group as a main effect, as was done for the analysis of the pooled iDMTs [13].",100.0
1772,PRECIS-2,Patients were required to have received a single iDMT (except natalizumab) continuously for at least 6 months prior to study initiation and to be candidates for therapy change.,fulltext,Patients were required to have received a single iDMT (except natalizumab) continuously for at least 6 months prior to study initiation and to be candidates for therapy change.,100.0
1772,PRECIS-2,The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months.,fulltext,The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months.,100.0
1773,PRECIS-2,A 12-week resistance training program similar to the one described in this study was offered to CG after completion of the intervention.,fulltext,A 12-week resistance training program similar to the one described in this study was offered to CG after completion of the intervention.,100.0
1773,PRECIS-2,"To assess any training or detraining effect, as well as any difference between groups, MVIC, torque, average power and muscle endurance raw values were examined using two-way ANOVA with repeated measurements for group and time.",fulltext,"To assess any training or detraining effect, as well as any difference between groups, MVIC, torque, average power and muscle endurance raw values were examined using two-way ANOVA with repeated measurements for group and time.",100.0
1773,PRECIS-2,"After a standardized cycling warm-up, and one set of 5 repetitions (reps) with a light load, participants performed 3 sets of 8–12 reps with a load that was progressively increased from 35 to 70% of MVIC through the training period.",fulltext,"After a standardized cycling warm-up, and one set of 5 repetitions (reps) with a light load, participants performed 3 sets of 8–12 reps with a load that was progressively increased from 35 to 70% of MVIC through the training period.",100.0
1773,PRECIS-2,"The resistance training protocol improved maximal strength and muscle power, but not muscle endurance.",fulltext,"The resistance training protocol improved maximal strength and muscle power, but not muscle endurance.",100.0
1773,PRECIS-2,"Testing was performed on three different occasions: before (week 0) and after (week 12) the training program, and after the detraining period (week 24).",fulltext,"Testing was performed on three different occasions: before (week 0) and after (week 12) the training program, and after the detraining period (week 24).",100.0
1773,PRECIS-2,All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.,fulltext,All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.,100.0
1773,PRECIS-2,"The patient inclusion criteria included a confirmed disease diagnosis by a neurologist, according to Mc-Donald criteria (McDonald, 2001); ability to walk (with or without aid) at least 20 m without rest; absence of other diseases that might have affected muscle function.",fulltext,"The patient inclusion criteria included a confirmed disease diagnosis by a neurologist, according to Mc-Donald criteria (McDonald, 2001); ability to walk (with or without aid) at least 20 m without rest; absence of other diseases that might have affected muscle function.",100.0
1773,PRECIS-2,"Participants were randomly assigned to two different groups, the exercise group (EG) or the control group (CG).",fulltext,"Participants were randomly assigned to two different groups, the exercise group (EG) or the control group (CG).",100.0
1773,PRECIS-2,"The EG improved MVIC (P = 0.004), torque (P = 0.004) and average power (P < 0.001) after the resistance training period.",fulltext,"The EG improved MVIC (P = 0.004), torque (P = 0.004) and average power (P < 0.001) after the resistance training period.",100.0
1773,PRECIS-2,"Data were analyzed using SPSS® 17.0 (SPSS Inc., USA). Results are presented as mean ± standard deviation (SD). Shapiro-Wilk normality test was used to assess normal data distribution.",fulltext,"Data were analyzed using SPSS® 17.0 (SPSS Inc., USA). Results are presented as mean ± standard deviation (SD). Shapiro-Wilk normality test was used to assess normal data distribution.",100.0
1773,PRECIS-2,"The EG, which included 16 women and 14 men (49.6 ± 11.0 yr), performed 12 weeks of resistance training followed by a detraining period where resistance exercise or other structured physical activity was avoided.",fulltext,"The EG, which included 16 women and 14 men (49.6 ± 11.0 yr), performed 12 weeks of resistance training followed by a detraining period where resistance exercise or other structured physical activity was avoided.",100.0
1773,PRECIS-2,"After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",fulltext,"After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",100.0
1773,PRECIS-2,"Subjects performed coupled concentric-eccentric bilateral seated knee extension training using a weight stack machine (BH® Fitness Nevada Pro-T, Spain) twice per week during 12 weeks, with at least 48 h of rest between sessions.",fulltext,"Subjects performed coupled concentric-eccentric bilateral seated knee extension training using a weight stack machine (BH® Fitness Nevada Pro-T, Spain) twice per week during 12 weeks, with at least 48 h of rest between sessions.",100.0
1773,PRECIS-2,All participants were recruited among six MS rehabilitation centers within the region of Castilla y León (Spain).,fulltext,All participants were recruited among six MS rehabilitation centers within the region of Castilla y León (Spain).,100.0
1773,PRECIS-2,All subjects taking part in the study (n = 42) completed all the scheduled testing protocols.,fulltext,All subjects taking part in the study (n = 42) completed all the scheduled testing protocols.,100.0
648,PRECIS-2,"The trial was discussed with all eligible women and their partners and relatives as appropriate. If the woman agreed to participate, she signed a formal consent form or used the method of recording consent permitted in that setting.",fulltext,"The trial was discussed with all eligible women and their partners and relatives as appropriate. If the woman agreed to participate, she signed a formal consent form or used the method of recording consent permitted in that setting.",100.0
648,PRECIS-2,There were no statistically significant differences within any of the intervention pairs for the primary outcome.,fulltext,There were no statistically significant differences within any of the intervention pairs for the primary outcome.,100.0
648,PRECIS-2,"All investigators, surgeons, and participants were unmasked to treatment allocation.",fulltext,"All investigators, surgeons, and participants were unmasked to treatment allocation.",100.0
648,PRECIS-2,"Data were collected at trial entry, immediately after surgery, at hospital discharge, and at about 6 weeks after delivery.",fulltext,"Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at about 6 weeks after delivery.",100.0
648,PRECIS-2,Pregnant women were eligible if they were to undergo their first or second caesarean section through a planned transverse abdominal incision.,fulltext,Pregnant women were eligible if they were to undergo their first or second caesarean section through a planned transverse abdominal incision.,100.0
648,PRECIS-2,All non-allocated surgical elements and all other aspects of the caesarean section procedure were undertaken at the discretion of the surgeon.,fulltext,All non-allocated surgical elements and all other aspects of the caesarean section procedure were undertaken at the discretion of the surgeon.,100.0
648,PRECIS-2,"CORONIS was undertaken at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan.",fulltext,"CORONIS was undertaken at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan.",100.0
648,PRECIS-2,Women were analysed in the groups into which they were allocated.,fulltext,Women were analysed in the groups into which they were allocated.,100.0
650,PRECIS-2,Patients with type 2 diabetes (n=264) selected by a self-administered questionnaire aimed at measuring emotional distress and diabetes-related reduced daily functioning.,fulltext,Patients with type 2 diabetes (n=264) selected by a self-administered questionnaire aimed at measuring emotional distress and diabetes-related reduced daily functioning.,100.0
650,PRECIS-2,Patients who experienced problems of daily functioning and emotional health problems were offered consultations for SMS.,fulltext,Patients who experienced problems of daily functioning (DFT >4) and emotional health problems (moderate scores on at least one subscale of the 4DSQ) were offered consultations for SMS.,100.0
650,PRECIS-2,Financial reimbursement for the extra time spent on SMS was added to the bundled payment arrangement for diabetes care.,fulltext,Financial reimbursement for the extra time spent on SMS was added to the bundled payment arrangement for diabetes care.,100.0
650,PRECIS-2,All the family practices of one regional organisation of GPs (a so-called ‘care group’) in the South of the Netherlands were eligible to participate in the study.,fulltext,All the family practices of one regional organisation of GPs (a so-called ‘care group’) in the South of the Netherlands were eligible to participate in the study.,100.0
650,PRECIS-2,Analyses were performed on an intention-to-treat basis.,fulltext,Analyses were performed on an intention-to-treat basis.,100.0
650,PRECIS-2,Outcomes were measured at baseline and at 4-month and 12-month follow-ups.,fulltext,Outcomes were measured at baseline and at 4-month and 12-month follow-ups.,100.0
650,PRECIS-2,"PNs supported patients in the processes of defining problems and finding solutions themselves, by applying problem-solving and reattribution techniques.",fulltext,"PNs supported patients in the processes of defining problems and finding solutions themselves, by applying problem-solving and reattribution techniques.",100.0
650,PRECIS-2,A regional care group in the Netherlands consisting of 77 family practices.,fulltext,A regional care group in the Netherlands consisting of 77 family practices.,100.0
650,PRECIS-2,The eligibility criteria changed from having a mild to moderate depression towards suffering from both emotional distress and interference in their daily functioning due to the burden of diabetes.,fulltext,The eligibility criteria changed from having a mild to moderate depression towards suffering from both emotional distress and interference in their daily functioning due to the burden of diabetes.,100.0
650,PRECIS-2,"From the 3822 patients with diabetes who were sent a screening questionnaire, 264 patients gave informed consent to participate in the trial.",fulltext," From all 1805 patients who participated in the screening, 357 (20%) met the detection criteria and were invited to take part in the trial. A total of 264 patients (74%) gave informed consent to participate in the tria",79.43262411347519
650,PRECIS-2,"PNs in the intervention arm were trained in SMS, whereas PNs in the control arm provided usual diabetes care, conforming to the Dutch guidelines.",fulltext,"PNs in the intervention arm were trained in SMS, whereas PNs in the control arm provided usual diabetes care, conforming to the Dutch guidelines.",100.0
650,PRECIS-2,The primary outcome measure was a dichotomised score on a Visual Analogue Scale that measured the perceived effect of diabetes on daily functioning.,fulltext,The primary outcome measure was a dichotomised score on a Visual Analogue Scale that measured the perceived effect of diabetes on daily functioning.,100.0
651,PRECIS-2,Practice staffs were asked to provide each patient with a written individualized asthma-action plan.,fulltext,Practice staffs were asked to provide each patient with a written individualized asthma-action plan.,100.0
651,PRECIS-2,"For patients receiving an LTRA or an inhaled glucocorticoid as first-line controller therapy, MiniAQLQ scores were equivalent at 2 months, but at 2 years, these scores did not meet our prespecified criterion for equivalence, since the lower boundary of the 95% CI was –0.35.",fulltext,"For patients receiving an LTRA or an inhaled glucocorticoid as first-line controller therapy, MiniAQLQ scores were equivalent at 2 months, but at 2 years, these scores did not meet our prespecified criterion for equivalence, since the lower boundary of the 95% CI was –0.35.",100.0
651,PRECIS-2,"The primary funder and sponsor (National Coordinating Centre for Health Technology Assessment U.K.) provided input with regard to the study design through its commissioning and monitoring brief but played no role in data collection, analysis, or interpretation; the writing of the article; or the decision to submit the article for publication.",fulltext,"The primary funder and sponsor (National Coordinating Centre for Health Technology Assessment U.K.) provided input with regard to the study design through its commissioning and monitoring brief but played no role in data collection, analysis, or interpretation; the writing of the article; or the decision to submit the article for publication.",100.0
651,PRECIS-2,"We designed these two pragmatic trials to maximize external validity (applicability or generalizability), with the goal of studying a heterogeneous real-world population.",fulltext,"We designed these two pragmatic trials7 to maximize external validity (applicability or generalizability), with the goal of studying a heterogeneous real-world population.",100.0
651,PRECIS-2,Both trials were conducted in accordance with the protocol.,fulltext,Both trials were conducted in accordance with the protocol.,100.0
651,PRECIS-2,"Patients were responsible for obtaining their own medications, as would occur in real life.",fulltext,"Patients were responsible for obtaining their own medications, as would occur in real life.",100.0
651,PRECIS-2,"We considered but rejected the addition of a placebo group when designing the study, since we believe it would have been unethical to assign patients to placebo for 2 years.",fulltext,"We considered but rejected the addition of a placebo group when designing the study, since we believe it would have been unethical to assign patients to placebo for 2 years.",100.0
651,PRECIS-2,"Data collection and statistical analyses were performed by study personnel who were unaware of the treatment assignments; questionnaire-based data were collected under blinded conditions, and routine practice data (including a history of exacerbations) were extracted with the use of dedicated software.",fulltext,"Data collection and statistical analyses were performed by study personnel who were unaware of the treatment assignments; questionnaire-based data were collected under blinded conditions, and routine practice data (including a history of exacerbations) were extracted with the use of dedicated software.",100.0
651,PRECIS-2,The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years.,fulltext,The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years.,100.0
651,PRECIS-2,Adherence to an LTRA was better than it was to the other drugs in both trials.,fulltext,Adherence to an LTRA was better than it was to the other drugs in both trials.,100.0
651,PRECIS-2,Mean improvements over a period of 2 years in both the first-line controller and the add-on therapy trials were substantially greater than the MID for questionnaire scores measuring asthma-related quality of life and asthma control.,fulltext,Mean improvements over a period of 2 years in both the first-line controller and the add-on therapy trials were substantially greater than the MID for questionnaire scores measuring asthma-related quality of life and asthma control.,100.0
651,PRECIS-2,Multiple imputation was used where data were missing.,fulltext,Multiple imputation was used where data were missing.,100.0
651,PRECIS-2,"The study was powered for equivalence in the MiniAQLQ score, with the equivalence boundary set at a 95% CI of less than 0.3 for the MiniAQLQ score (i.e., equivalence was declared if the 95% CI was wholly included between –0.3 and 0.3).",fulltext,"The study was powered for equivalence in the MiniAQLQ score, with the equivalence boundary set at a 95% CI of less than 0.3 for the MiniAQLQ score (i.e., equivalence was declared if the 95% CI was wholly included between –0.3 and 0.3).",100.0
651,PRECIS-2,Choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.,fulltext,Choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.,100.0
651,PRECIS-2,The protocol discouraged substantial treatment changes between randomization and the 2-month visit.,fulltext,The protocol discouraged substantial treatment changes between randomization and the 2-month visit.,100.0
651,PRECIS-2,"In the case of asthma, for example, the eligibility criteria in most such trials exclude an estimated 95% of patients with a current diagnosis of asthma, including smokers and those who have “insufficient” bronchodilator reversibility or impaired pulmonary function.",fulltext,"In the case of asthma, for example, the eligibility criteria in most such trials exclude an estimated 95% of patients with a current diagnosis of asthma, including smokers and those who have “insufficient” bronchodilator reversibility or impaired pulmonary function.",100.0
651,PRECIS-2,"Although such poor and differential adherence potentially reduces assay sensitivity (particularly when coupled with treatment crossover), thus biasing results toward equivalence, both poor and differential adherence rates are realities of real-world prescribing and thus part of the treatment effect.",fulltext,"Although such poor and differential adherence potentially reduces assay sensitivity (particularly when coupled with treatment crossover), thus biasing results toward equivalence, both poor and differential adherence rates are realities of real-world prescribing6 and thus part of the treatment effect.",100.0
651,PRECIS-2,"Data for asthma-related quality of life and asthma control were available over a period of 21 months for 95% and 96% of the patients in the first-line controller and add-on therapy trials, respectively, which are completion rates higher than those in most long-term asthma-therapy trials.",fulltext,"Data for asthma-related quality of life and asthma control were available over a period of 21 months for 95% and 96% of the patients in the first-line controller and add-on therapy trials, respectively, which are completion rates higher than those in most long-term asthma-therapy trials.",100.0
655,PRECIS-2,A multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals.,fulltext,A multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals.,100.0
655,PRECIS-2,All available data from the randomized patients were used in the mixed models.,fulltext,All available data from the randomized patients were used in the mixed models.,100.0
655,PRECIS-2,All patients gave written informed consent.,fulltext,All patients gave written informed consent.,100.0
655,PRECIS-2,"After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months.",fulltext,"After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months.",100.0
655,PRECIS-2,Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital.,fulltext,Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital.,100.0
655,PRECIS-2,"Recruited patients (recruitment visit, −1) attended an initial 8-week outpatient-based PR programme conducted in each hospital rehabilitation department.",fulltext,"Recruited patients (recruitment visit, −1) attended an initial 8-week outpatient-based PR programme conducted in each hospital rehabilitation department.",100.0
655,PRECIS-2,Exercise tolerance (the ability to sustain exercise) was assessed using distance covered in the 6MWT.,fulltext,Exercise tolerance (the ability to sustain exercise) was assessed using distance covered in the 6MWT.,100.0
655,PRECIS-2,"Patient selection criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3–7) according to international guidelines and having been clinically stable for the previous 4 weeks.",fulltext,"Patient selection criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3–7) according to international guidelines9 and having been clinically stable for the previous 4 weeks ",100.0
657,PRECIS-2,Eighty people with Expanded Disability Status scores of 1 to 6.5 participated in this trial.,fulltext,Eighty people with Expanded Disability Status scores of 1 to 6.5 participated in this trial.,100.0
657,PRECIS-2,"The physical therapists had varied experience (between 7–25 years) and certification (2 had both a master's degree in neurological physical therapy and were clinical specialists in neurological physical therapy, 1 was a clinical specialist in neurological physical therapy, and 3 were generalists in physical therapy).",fulltext,"The physical therapists had varied experience (between 7–25 years) and certification (2 had both a master's degree in neurological physical therapy and were clinical specialists in neurological physical therapy, 1 was a clinical specialist in neurological physical therapy, and 3 were generalists in physical therapy).",100.0
657,PRECIS-2,"All participants with postintervention test assessment scores were included, although some had missing observations.",fulltext,"All participants with postintervention test assessment scores were included, although some had missing observations.",100.0
657,PRECIS-2,Participants in the intervention group were encouraged not to seek any physical therapy other than GroupCoreDIST during the 6 weeks of the intervention.,fulltext,Participants in the intervention group were encouraged not to seek any physical therapy other than GroupCoreDIST during the 6 weeks of the intervention.,100.0
657,PRECIS-2,"The TIS-NV, which requires quality of movement and cooperation between body segments in dynamic sitting balance,29 detected a short-term improvement of 19% in the intervention group, which we consider a clinically meaningful change.",fulltext,"The TIS-NV, which requires quality of movement and cooperation between body segments in dynamic sitting balance,29 detected a short-term improvement of 19% in the intervention group, which we consider a clinically meaningful change.",100.0
657,PRECIS-2,The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway.,fulltext,The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway.,100.0
657,PRECIS-2,"The inclusion criteria were as follows: (1) diagnosed with MS in accordance with the McDonald criteria27; (2) registered at the MS outpatient clinic; (3) living in 1 of 6 selected municipalities; (4) aged 18 years or older; (5) capable of providing signed written informed consent; and (6) EDSS score between 1 and 6.5 (1 = minor disability, 6.5 = able to walk 20 m with or without a walking aid).",fulltext,"The inclusion criteria were as follows: (1) diagnosed with MS in accordance with the McDonald criteria27; (2) registered at the MS outpatient clinic; (3) living in 1 of 6 selected municipalities; (4) aged 18 years or older; (5) capable of providing signed written informed consent; and (6) EDSS score between 1 and 6.5 (1 = minor disability, 6.5 = able to walk 20 m with or without a walking aid).",100.0
657,PRECIS-2,"The physical therapists individualized the exercises by tailoring them according to each individual's symptoms, disability level, and general well-being, and they intensified the exercises by increasing number of repetitions, level of difficulty, and/or by adding motor-cognitive dual tasks as movement quality improved.",fulltext,"The physical therapists individualized the exercises by tailoring them according to each individual's symptoms, disability level, and general well-being, and they intensified the exercises by increasing number of repetitions, level of difficulty, and/or by adding motor-cognitive dual tasks as movement quality improved.",100.0
657,PRECIS-2,"Assessments were conducted at baseline and at weeks 7, 18, and 30.",fulltext,"Assessments were conducted at baseline and at weeks 7, 18, and 30.",100.0
657,PRECIS-2,"In August 2015, 1 of the MS nurses at the Department of Neurology, Nordland Hospital Trust in Bodø, Norway, sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic, had EDSS scores of 0 to 7, and lived in 1 of the 6 municipalities included in the study.",fulltext,"In August 2015, 1 of the MS nurses at the Department of Neurology, Nordland Hospital Trust in Bodø, Norway, sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic, had EDSS scores of 0 to 7, and lived in 1 of the 6 municipalities included in the study.",100.0
663,PRECIS-2,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.",fulltext,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.",100.0
663,PRECIS-2,"The primary comparisons showed that BMCT, but not PRT, improved T25FW, SSST, and self-perceived gait function when compared to CON.",fulltext,"The primary comparisons showed that BMCT, but not PRT, improved T25FW, SSST, and self-perceived gait function when compared to CON.",100.0
663,PRECIS-2,"Analyses were carried out as intention-to-treat, where all participants who completed the baseline assessment were included regardless of their adherence to the allocated intervention.",fulltext,"Analyses were carried out as intention-to-treat, where all participants who completed the baseline assessment were included regardless of their adherence to the allocated intervention.",100.0
663,PRECIS-2,The follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.,fulltext,The follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.,100.0
663,PRECIS-2,"This study was designed as a multi-centered, randomized control trial with two intervention groups and a control group (CON).",fulltext,"This study was designed as a multi-centered, randomized control trial with two intervention groups and a control group (CON).",100.0
663,PRECIS-2,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society. The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks. Exclusion criteria were as follows: co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT >1 session/week within the last 3 months.",fulltext,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society. The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks. Exclusion criteria were as follows: co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT >1 session/week within the last 3 months.",100.0
663,PRECIS-2,All training sessions were supervised by physiotherapists who were trained to deliver the intervention.,fulltext,All training sessions were supervised by physiotherapists who were trained to deliver the intervention.,100.0
663,PRECIS-2,Both BMCT and PRT significantly reduced fatigue impact.,fulltext,Both BMCT and PRT significantly reduced fatigue impact.,100.0
663,PRECIS-2,The BMCT intervention consisted of 20 1-hour training sessions over 10 weeks (two sessions/week). All sessions started with a 10-minute warm-up on a stationary bicycle or treadmill.,fulltext,The BMCT intervention consisted of 20 1-hour training sessions over 10 weeks (two sessions/week). All sessions started with a 10-minute warm-up on a stationary bicycle or treadmill.,100.0
664,PRECIS-2,"Of 349 potential participants who were assessed for eligibility, 120 (34%) were randomised.",fulltext,"Of 349 potential participants who were assessed for eligibility, 120 (34%) were randomised.",100.0
664,PRECIS-2,A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,fulltext,A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,100.0
664,PRECIS-2,"Outcomes were assessed at baseline, and at three months (post-intervention) and nine months after randomisation.",fulltext,"Outcomes were assessed at baseline, and at three months (post-intervention) and nine months after randomisation.",100.0
664,PRECIS-2,"The prescribed strength training was based on individual functional needs, as assessed by the trial physiotherapist.",fulltext,"The prescribed strength training was based on individual functional needs, as assessed by the trial physiotherapist.",100.0
664,PRECIS-2,"During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home environment.",fulltext,"During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home environment.",100.0
664,PRECIS-2,The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ).,fulltext,The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ).,100.0
664,PRECIS-2,An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme.,fulltext,An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme.,100.0
664,PRECIS-2,"All analyses were by intention to treat, whereby participants were analysed in the arm to which they were randomised irrespective of whether they complied with the intervention.",fulltext,"All analyses were by intention to treat, whereby participants were analysed in the arm to which they were randomised irrespective of whether they complied with the intervention.",100.0
664,PRECIS-2,The supervised exercise sessions incorporated cognitive-behavioural techniques to promote long-term participation in physical activity.,fulltext,"The supervised exercise sessions incorporated cognitive-behavioural techniques (e.g. goal setting, finding social support, understanding the costs/benefits of exercise, etc.) to promote long-term participation in physical activity.",100.0
664,PRECIS-2,"The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",fulltext,"The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria,9 with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",100.0
665,PRECIS-2,The PCTs delivering CCBT reported that they assumed that patients who were non-adherent and non-contactable beyond two weeks had discontinued treatment and made no further effort to contact them.,fulltext,The PCTs delivering CCBT reported that they assumed that patients who were non-adherent and non-contactable beyond two weeks had discontinued treatment and made no further effort to contact them.,100.0
665,PRECIS-2,Our initial aim was to recruit 24 participants between 22 October 2008 and 31 January 2009 (101 days; 7.1 participants/month) with candidates identified by three neurologists working in a single weekly specialist MS clinic (Sheffield Teaching Hospitals NHS Trust).,fulltext,Our initial aim was to recruit 24 participants between 22 October 2008 and 31 January 2009 (101 days; 7.1 participants/month) with candidates identified by three neurologists working in a single weekly specialist MS clinic (Sheffield Teaching Hospitals NHS Trust).,100.0
665,PRECIS-2,Only one out of the five participating PCTs around the Sheffield centre formally provided any kind of community facility for accessing CCBT; PCT staff warned that clients rarely used the facility and it was closed during the course of the study.,fulltext,Only one out of the five participating PCTs around the Sheffield centre formally provided any kind of community facility for accessing CCBT; PCT staff warned that clients rarely used the facility and it was closed during the course of the study.,100.0
665,PRECIS-2,"From the 288 invitation packs given out by Sheffield neurologists in the MS clinic, forms were completed and returned by 63 (21.8%) candidates from which we randomised 13 in 281 days (4.5% recruitment yield), or 1.4 participants per month.",fulltext,"From the 288 invitation packs given out by Sheffield neurologists in the MS clinic, forms were completed and returned by 63 (21.8%) candidates from which we randomised 13 in 281 days (4.5% recruitment yield), or 1.4 participants per month.",100.0
665,PRECIS-2,"Of the 12 patients in the CCBT arm, 9 (75%) completed at least four CCBT sessions. This translated to a reasonably high compliance rate of CCBT although only six (50%) of the patients in this arm completed all intended eight CCBT sessions.",fulltext,"Of the 12 patients in the CCBT arm, 9 (75%) completed at least four CCBT sessions. This translated to a reasonably high compliance rate of CCBT although only six (50%) of the patients in this arm completed all intended eight CCBT sessions.",100.0
665,PRECIS-2,The MS services in both sites are specific entities and not general neurology clinics.,fulltext,The MS services in both sites are specific entities and not general neurology clinics.,100.0
665,PRECIS-2,The patient reported outcome measure which the participants felt best reflected their concerns was the MSIS-29.,fulltext,The patient reported outcome measure which the participants felt best reflected their concerns was the MSIS-29.,100.0
665,PRECIS-2,Recruitment through out-patient clinics was somewhat slower than through screening questionnaire mail-out but the overall recruitment yield was similar.,fulltext,Recruitment through out-patient clinics was somewhat slower than through screening questionnaire mail-out but the overall recruitment yield was similar.,100.0
665,PRECIS-2,Primary outcome assessments were available for 21 (88%) participants at 8 weeks from randomisation (or end of treatment if later) and 18 (75%) participants at a further three months' follow-up.,fulltext,Primary outcome assessments were available for 21 (88%) participants at 8 weeks from randomisation (or end of treatment if later) and 18 (75%) participants at a further three months' follow-up.,100.0
665,PRECIS-2,"Exclusion criteria were: poor English language skills or cognitive function (score of less than 24 on Mini Mental State Examination [20]); BDI score of at least 29 on two consecutive occasions; active suicidal ideas; current or life-time diagnosis of psychosis, organic mental disorder or substance dependency; Kurtzke Expanded Disability Status Scale (EDSS) score of 8.5 or above [21]).",fulltext,"Exclusion criteria were: poor English language skills or cognitive function (score of less than 24 on Mini Mental State Examination [20]); BDI score of at least 29 on two consecutive occasions; active suicidal ideas; current or life-time diagnosis of psychosis, organic mental disorder or substance dependency; Kurtzke Expanded Disability Status Scale (EDSS) score of 8.5 or above [21]).",100.0
665,PRECIS-2,Two participants in each arm were lost to follow-up at 21 weeks post-randomisation.,fulltext,Two participants in each arm were lost to follow-up at 21 weeks post-randomisation.,100.0
665,PRECIS-2,"Primary analysis was an Intention To Treat (ITT) analysis which analysed all 24 participants according to their randomised treatment assignment ignoring non compliance, protocol deviations and withdrawal.",fulltext,"Primary analysis was an Intention To Treat (ITT) analysis which analysed all 24 participants according to their randomised treatment assignment ignoring non compliance, protocol deviations and withdrawal.",100.0
665,PRECIS-2,No PCT with whom we worked offered advice or support for defining problems on which to work or applying the CBT model to individual problems.,fulltext,No PCT with whom we worked offered advice or support for defining problems on which to work or applying the CBT model to individual problems.,100.0
665,PRECIS-2,"Inclusion criteria were: age of 18 years or above; BDI score of at least 14 on two consecutive occasions and no treatment from psychologist, psychotherapist or psychiatrist within the last three months.",fulltext,"Inclusion criteria were: age of 18 years or above; BDI score of at least 14 on two consecutive occasions and no treatment from psychologist, psychotherapist or psychiatrist within the last three months.",100.0
666,PRECIS-2,"Key inclusion criteria permitted the participation of men or women ≥18 years of age with confirmed and documented RRMS diagnosis (as defined by the Revised McDonald criteria) (Polman et al., 2011), Kurtzke Expanded Disability Status Scale (EDSS) score of 0 to 5.5 at the screening visit, and, 30 days prior to randomization, a stable neurological condition, relapse-free status, and no use of any corticosteroid or adrenocorticotropic hormone treatment.",fulltext,"Key inclusion criteria permitted the participation of men or women ≥18 years of age with confirmed and documented RRMS diagnosis (as defined by the Revised McDonald criteria) (Polman et al., 2011), Kurtzke Expanded Disability Status Scale (EDSS) score of 0 to 5.5 at the screening visit, and, 30 days prior to randomization, a stable neurological condition, relapse-free status, and no use of any corticosteroid or adrenocorticotropic hormone treatment.",100.0
666,PRECIS-2,"Patients (N = 861) were randomly assigned 1:1 to receive GA20 (n = 430) or GA40 (n = 431) during the core phase. The primary endpoint was patient-reported medication satisfaction using the Medication Satisfaction Questionnaire (MSQ). Secondary endpoints included self-reported convenience perception using the Treatment Satisfaction Questionnaire for Medication-9 convenience component, symptomatic changes (Modified Fatigue Impact Scale, MFIS), and Mental Health Inventory (MHI). Treatment adherence was measured by Multiple Sclerosis Treatment Adherence Questionnaire. Results from the core phase were included.",fulltext,"Patients (N = 861) were randomly assigned 1:1 to receive GA20 (n = 430) or GA40 (n = 431) during the core phase. The primary endpoint was patient-reported medication satisfaction using the Medication Satisfaction Questionnaire (MSQ). Secondary endpoints included self-reported convenience perception using the Treatment Satisfaction Questionnaire for Medication-9 convenience component, symptomatic changes (Modified Fatigue Impact Scale, MFIS), and Mental Health Inventory (MHI). Treatment adherence was measured by Multiple Sclerosis Treatment Adherence Questionnaire. Results from the core phase were included.",100.0
666,PRECIS-2,"Patients’ adherence to treatment measured at Months 1, 3, and 6 using the MS-TAQ questionnaire showed consistently greater adherence to treatment in patients receiving GA40 compared with those receiving GA20 (Fig. 5).",fulltext,"Patients’ adherence to treatment measured at Months 1, 3, and 6 using the MS-TAQ questionnaire showed consistently greater adherence to treatment in patients receiving GA40 compared with those receiving GA20 (Fig. 5).",100.0
666,PRECIS-2,"The intention-to-treat (ITT) analysis set included all randomly assigned participants and were analyzed according to the treatment group to which they were randomly assigned, regardless of which treatment they actually received.",fulltext,"The intention-to-treat (ITT) analysis set included all randomly assigned participants and were analyzed according to the treatment group to which they were randomly assigned, regardless of which treatment they actually received.",100.0
666,PRECIS-2,"Eligible patients were randomly assigned 1:1 to receive subcutaneous injections of GA40 (n = 431) or GA20 (n = 430). Five scheduled visits at study sites occurred at screening (within 2 weeks prior to baseline), baseline (Month 0), and Months 1, 3, and 6 (end of the core phase). Patients also participated in self-reported, daily at-home MSQ assessments on Days 1 through 7 after the baseline visit.",fulltext,"Eligible patients were randomly assigned 1:1 to receive subcutaneous injections of GA40 (n = 431) or GA20 (n = 430). Five scheduled visits at study sites occurred at screening (within 2 weeks prior to baseline), baseline (Month 0), and Months 1, 3, and 6 (end of the core phase). Patients also participated in self-reported, daily at-home MSQ assessments on Days 1 through 7 after the baseline visit.",100.0
666,PRECIS-2,The primary endpoint was patient-reported medication satisfaction using the Medication Satisfaction Questionnaire (MSQ).,fulltext,The primary endpoint was patient-reported medication satisfaction using the Medication Satisfaction Questionnaire (MSQ).,100.0
666,PRECIS-2,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",fulltext,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",100.0
666,PRECIS-2,"Key exclusion criteria were previous exposure to GA40, a progressive form of MS or neuromyelitis optica, the use of experimental or investigational drugs, participation in clinical drug studies within the 6 months before screening, recent use of immunosuppressive medications or immunoglobulins/monoclonal antibodies, or previous use of alemtuzumab, cladribine, cyclophosphamide, or mitoxantrone.",fulltext,"Key exclusion criteria were previous exposure to GA40, a progressive form of MS or neuromyelitis optica, the use of experimental or investigational drugs, participation in clinical drug studies within the 6 months before screening, recent use of immunosuppressive medications or immunoglobulins/monoclonal antibodies, or previous use of alemtuzumab, cladribine, cyclophosphamide, or mitoxantrone.",100.0
666,PRECIS-2,"The overall treatment-emergent adverse event (TEAE) profile in both treatment groups was consistent with previous findings (Wolinsky et al., 2015) (Table 2). A significantly lower percentage of patients in the GA40 cohort (8.6%) reported injection-site pruritus than those in the GA20 cohort (13.6%, p = 0.023).",fulltext,"The overall treatment-emergent adverse event (TEAE) profile in both treatment groups was consistent with previous findings (Wolinsky et al., 2015) (Table 2). A significantly lower percentage of patients in the GA40 cohort (8.6%) reported injection-site pruritus than those in the GA20 cohort (13.6%, p = 0.023).",100.0
668,PRECIS-2,"Participants were recruited through a statewide organization providing education and support to people with MS, and a large specialist MS outpatient clinic. Recruitment information flyers were sent by mail to all potential participants registered on the mailing lists of both organizations.",fulltext,"Participants were recruited through a statewide organization providing education and support to people with MS, and a large specialist MS outpatient clinic. To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate. Volunteers were excluded if they had an acute exacerbation of MS within 2 months of starting the program, had benign or progressive/relapsing types of MS, had a serious unstable medical condition, had any concurrent condition, for example stroke, or had participated in a PRT program in the 6 months before training started. Recruitment information flyers were sent by mail to all potential participants registered on the mailing lists of both organizations.",100.0
668,PRECIS-2,"There was good adherence with the training program (92%), compared with the control group’s adherence with the increased attention and social activities program (62%).",fulltext,"There was good adherence with the training program (92%), compared with the control group’s adherence with the increased attention and social activities program (62%).",100.0
668,PRECIS-2,Participants were asked to return to their usual activities and not to continue or commence resistance training until after the follow-up assessment session.,fulltext,Participants were asked to return to their usual activities and not to continue or commence resistance training until after the follow-up assessment session.,100.0
668,PRECIS-2,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",fulltext,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",100.0
668,PRECIS-2,The exercises targeted the key lower limb muscles for supporting body weight and for generating and absorbing power during walking.,fulltext,The exercises targeted the key lower limb muscles for supporting body weight and for generating and absorbing power during walking.,100.0
668,PRECIS-2,Participants in the control group received ‘usual care’ plus a social program.,fulltext,Participants in the control group received ‘usual care’ plus a social program.,100.0
668,PRECIS-2,Analysis of covariance using the baseline measures as covariates was used to determine whether the PRT group improved more than the control group immediately after the 10-week program.,fulltext," To determine whether the PRT group improved more than the control group immediately after the 10-week program,",60.32608695652174
668,PRECIS-2,No between-group differences were detected after 10 weeks or 22 weeks for symptoms of muscle stiffness or muscle spasm.,fulltext,No between-group differences were detected after 10 weeks or 22 weeks for symptoms of muscle stiffness or muscle spasm.,100.0
668,PRECIS-2,"Participants were recruited through a statewide organization providing education and support to people with MS, and a large specialist MS outpatient clinic. To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",fulltext,"Participants were recruited through a statewide organization providing education and support to people with MS, and a large specialist MS outpatient clinic. To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",100.0
668,PRECIS-2,"At the end of the 10-week program, participants in the PRT group did not significantly increase the distance they walked over 2 min or increase their maximal walking speed compared with the control group.",fulltext,"at the end of the 10-week program, participants in the PRT group did not significantly increase the distance they walked over 2 min (2.6 m, 95% CI -4.0–9.1), or increase their maximal walking speed (0.04 m s−1, 95% CI -0.05–0.13) compared with the control group.",100.0
669,PRECIS-2,The addition of two group training sessions with direct supervision by the researchers allowed for expert advice and social interaction and peer support.,fulltext,The addition of two group training sessions with direct supervision by the researchers allowed for expert advice and social interaction and peer support.,100.0
669,PRECIS-2,Participants wore an activity tracker at the waist that registered the intensity of steps per minute.,fulltext,participants were able to run 5 km without interruption at 12 weeks. pwMS wore an activity tracker (Withings Pulse Ox) at the waist that registered the intensity of steps per minute.,100.0
669,PRECIS-2,Exclusion criteria were reports to have run 5 km in the preceding 6 months or a relapse occurring in the preceding 3 months.,fulltext,Exclusion criteria were reports to have run 5 km in the preceding 6 months or a relapse occurring in the preceding 3 months.,100.0
669,PRECIS-2,Participants received training instructions by email and were asked to train three times weekly according to a personalized training intensity schedule.,fulltext,pervision. pwMS received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule ,94.07894736842105
669,PRECIS-2,"The primary outcome measures were physical fitness, walking capacity and perceived ability, functional mobility, and quality of life.",fulltext,"The primary outcome measures were physical fitness, walking capacity and perceived ability, functional mobility, and quality of life.",100.0
669,PRECIS-2,The EXP group completed a 12-week gradual “start-to-run” program in between time points.,fulltext,The EXP group completed a 12-week gradual “start-to-run” program in between time points.,100.0
669,PRECIS-2,"Secondary outcome measures were fatigue, cognitive function, brain volumes, and structural connectivity.",fulltext,"Secondary outcome measures were fatigue, cognitive function, brain volumes, and structural connectivity.",100.0
669,PRECIS-2,Participants were tested at two time points (0 and 12 weeks).,fulltext,Patients were tested at two time points (0 and 12 weeks).,91.80327868852459
669,PRECIS-2,"pwMS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",fulltext,"with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",99.39393939393939
669,PRECIS-2,Participants were asked to weekly upload data to allow remote supervision of the training adherence by the research assistant.,fulltext,Participants were asked to weekly upload data to allow remote supervision of the training adherence by the research assistant.,100.0
669,PRECIS-2,pwMS were assigned to the experimental (EXP) or the “waiting list control” (WLC) group prior to baseline testing.,fulltext,pwMS were assigned to the experimental (EXP) or the “waiting list control” (WLC) group prior to baseline testing.,100.0
669,PRECIS-2,Participants had a specific common goal which was to run together on a public event.,fulltext,Participants had a specific common goal which was to run together on a public event.,100.0
669,PRECIS-2,"pwMS received individualized training instructions during 12 weeks, to be performed in their community aiming to participate in a running event.",fulltext," received individualized training instructions during 12 weeks (3×/week), to be performed in their community aiming to participate in a running event.",97.22222222222221
669,PRECIS-2,"Participants performed their individual training session simultaneously, while being observed by the project dedicated researcher (MSc exercise physiology and PhD) and master students (rehabilitation sciences and physiotherapy).",fulltext,"Participants performed their individual training session simultaneously, while being observed by the project dedicated researcher (MSc exercise physiology and PhD) and master students (rehabilitation sciences and physiotherapy).",100.0
669,PRECIS-2,Recruited participants showed only mild walking impairment and likely had high exercise self-efficacy levels as they were willing to engage in an individual community-located running training.,fulltext,Recruited participants showed only mild walking impairment and likely had high exercise self-efficacy levels as they were willing to engage in an individual community-located running training.,100.0
669,PRECIS-2,Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.,fulltext,Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.,100.0
669,PRECIS-2,"During the first weeks, training consisted of longer walking bouts, interspersed with short 1′ running bouts. The relative amount of running gradually increased until participants were able to run 5 km without interruption at 12 weeks.",fulltext,"During the first weeks, training consisted of longer walking bouts, interspersed with short 1′ running bouts. The relative amount of running gradually increased until participants were able to run 5 km without interruption at 12 weeks.",100.0
669,PRECIS-2,Intention-to-treat analysis was performed.,fulltext,Intention-to-treat analysis was performed.,100.0
670,PRECIS-2,"Accordingly, if the current research was to conform to the requirements of model fit/ecological validity, it was incumbent on the therapists to construct individualized treatment plans recognizing the importance of the client's physical, psychological and emotional needs.",fulltext,"Accordingly, if the current research was to conform to the requirements of model fit/ecological validity (Menard, 2003; Mason et al., 2002), it was incumbent on the therapists to construct individualized treatment plans recognizing the importance of the client's physical, psychological and emotional needs.",100.0
670,PRECIS-2,"The clients presented to the clinic with a variety of impairments, including some specifically related to the disease process and others that were primarily musculoskeletal in origin.",fulltext,"The clients presented to the clinic with a variety of impairments, including some specifically related to the disease process and others that were primarily musculoskeletal in origin.",100.0
670,PRECIS-2,The treatment plans were approved by the clinical teacher in charge.,fulltext, treatment plans were approved by the clinical teacher in charge.,95.58823529411765
670,PRECIS-2,"Of the fifteen study participants, all had previously received a diagnosis of multiple sclerosis.",fulltext,"Of the fifteen study participants, all had previously received a diagnosis of multiple sclerosis.",100.0
670,PRECIS-2,"The MSSE survey measures perception, it can be suggested that higher self-efficacy scores reflect improved mood (i.e. reduced depression, anxiety and stress), and a better ability to cope with and adjust to the disease.",fulltext,"The MSSE survey measures perception, it can be suggested that higher self-efficacy scores reflect improved mood (i.e. reduced depression, anxiety and stress), and a better ability to cope with and adjust to the disease.",100.0
670,PRECIS-2,"The inclusion criterion for the study was a diagnosis of multiple sclerosis, and therefore the spectrum of clinical presentations was broad, as would be expected in this client population.",fulltext,"The inclusion criterion for the study was a diagnosis of multiple sclerosis, and therefore the spectrum of clinical presentations was broad, as would be expected in this client population.",100.0
670,PRECIS-2,"Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted. Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self selected on that basis.",fulltext,"Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted. Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self selected on that basis.",100.0
670,PRECIS-2,"The data were analyzed on an intention to treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups.",fulltext,"The data were analyzed on an intention to treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups.",100.0
670,PRECIS-2,"Self-Efficacy scores were obtained before the first treatment, mid-treatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",fulltext,"Self-Efficacy scores were obtained before the first treatment, mid-treatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",100.0
670,PRECIS-2,"The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client's needs.",fulltext,"The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client's needs.",100.0
670,PRECIS-2,"Massage therapy is aligned with the wellness paradigm of health and health care, which speaks to a holistic client centered approach to treatment.",fulltext,"Massage therapy is aligned with the wellness paradigm of health and health care (Alexander, 2006; Yates, 2004), which speaks to a holistic client centered approach to treatment.",100.0
670,PRECIS-2,"Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted.",fulltext,"Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted.",100.0
670,PRECIS-2,"Self-Efficacy [SE] was the outcome for the study, measured using the Multiple Sclerosis Self-Efficacy survey [MSSE].",fulltext,"Self-Efficacy [SE] was the outcome for the study, measured using the Multiple Sclerosis Self-Efficacy survey [MSSE].",100.0
670,PRECIS-2,"Clients attending the clinic were interviewed, and their case histories recorded. The research project was explained, and written informed consent was obtained.",fulltext,"Clients attending the clinic were interviewed, and their case histories recorded. The research project was explained, and written informed consent was obtained.",100.0
671,PRECIS-2,"Key inclusion criteria were age older than 18 years, a diagnosis of progressive multiple sclerosis (primary or secondary) according to McDonald's criteria, and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS).",fulltext,"Key inclusion criteria were age older than 18 years, a diagnosis of progressive multiple sclerosis (primary or secondary) according to McDonald's criteria,21 and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS).",100.0
671,PRECIS-2,"Participants were recruited through eight health-care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",fulltext,"Participants were recruited through eight health-care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",100.0
671,PRECIS-2,All participants received their usual health and social service input throughout the study period.,fulltext,All participants received their usual health and social service input throughout the study period.,100.0
671,PRECIS-2,"The intervention consisted of two home-based physiotherapy sessions (60 min each) to set up the standing frame programme, supported by six follow-up telephone calls (15 min per call).",fulltext,"The intervention consisted of two home-based physiotherapy sessions (60 min each) to set up the standing frame programme, supported by six follow-up telephone calls (15 min per call).",100.0
671,PRECIS-2,The primary clinical outcome was motor function measured by the Amended Motor Club Assessment (AMCA) score at week 36.,fulltext,The primary clinical outcome was motor function measured by the Amended Motor Club Assessment (AMCA) score at week 36.,100.0
671,PRECIS-2,"Participants were asked to stand for 30 min, three times per week over 20 weeks, and encouraged to continue in the longer term, although no further physiotherapy support was provided.",fulltext,"Participants were asked to stand for 30 min, three times per week over 20 weeks, and encouraged to continue in the longer term, although no further physiotherapy support was provided.",100.0
671,PRECIS-2,The study was undertaken in eight centres from two regions in the UK.,fulltext, undertaken in eight centres from two regions in the UK.,81.15942028985508
671,PRECIS-2,"The primary analysis of the primary outcome, AMCA score at 36 weeks, followed a modified intention-to-treat approach, regardless of compliance to the intervention.",fulltext,"The primary analysis of the primary outcome, AMCA score at 36 weeks, followed a modified intention-to-treat approach, regardless of compliance to the intervention.",100.0
671,PRECIS-2,"The study had assessor-blinded outcome assessments with use of clinician-rated and patient-rated measures at baseline, 20 weeks, and 36 weeks.",fulltext,"The study had assessor-blinded outcome assessments with use of clinician-rated and patient-rated measures at baseline, 20 weeks, and 36 weeks.",100.0
673,PRECIS-2,"The FI-led classes were not pre-defined, as the aim was to establish whether these classes were effective when encountered by those with MS in the community.",fulltext,"The FI-led classes were not pre-defined, as the aim was to establish whether these classes were effective when encountered by those with MS in the community.",100.0
673,PRECIS-2,"Participants were advised to exercise aerobically in the mode of their choice (walking, cycling, swimming or running), with the aim of exercising for 30 minutes, twice a week, at an intensity of 65% of the heart rate max, or a Borg’s rate of perceived exertion of 11–14.",fulltext,"Participants were advised to exercise aerobically in the mode of their choice (walking, cycling, swimming or running), with the aim of exercising for 30 minutes, twice a week, at an intensity of 65% of the heart rate max, or a Borg’s rate of perceived exertion of 11–14.",100.0
673,PRECIS-2,"They were delivered in community centres such as local gyms, hotels and health centres.",fulltext,"They were delivered in community centres such as local gyms, hotels and health centres.",100.0
673,PRECIS-2,The yoga intervention was also not predefined.,fulltext,The yoga intervention was also not predefined.,100.0
673,PRECIS-2,The PT-led exercise provided was pre-defined.,fulltext,The PT-led exercise provided was pre-defined.,100.0
673,PRECIS-2,"Participants were randomised in groups of eight to physiotherapist (PT)-led exercise (n = 80), yoga (n = 77), fitness instructor (FI)-led exercise (n = 86) and they took part in weekly community-based group exercise sessions.",fulltext,"Participants were randomised in groups of eight to physiotherapist (PT)-led exercise (n = 80), yoga (n = 77), fitness instructor (FI)-led exercise (n = 86) and they took part in weekly community-based group exercise sessions.",100.0
673,PRECIS-2,"The primary outcome was the Multiple Sclerosis Impact Scale (MSIS) 29v2 physical component, measured before and after the 10-week intervention.",fulltext,"The primary outcome was the Multiple Sclerosis Impact Scale (MSIS) 29v2 physical component, measured before and after the 10-week intervention.",100.0
673,PRECIS-2,"Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical.",fulltext,"Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical.",100.0
673,PRECIS-2,"Our study participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.",fulltext,"Our study participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.",100.0
673,PRECIS-2,"All interventions took place in groups of eight, for an hour per week, for 10 weeks.",fulltext,"All interventions took place in groups of eight, for an hour per week, for 10 weeks.",100.0
673,PRECIS-2,Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist.,fulltext,Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist.,100.0
673,PRECIS-2,All participants were analysed in the groups to which they were randomised.,fulltext,All participants were analysed in the groups to which they were randomised.,100.0
674,PRECIS-2,"In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.",fulltext,"In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.",100.0
674,PRECIS-2,"Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis (CARE-MS) II, a 2-year randomized, rater-blinded, active-controlled, head-to-head, phase 3 trial, compared efficacy and safety of alemtuzumab 12 mg with subcutaneous interferon-β-1a (SC IFN-β-1a) 44 μg in patients with RRMS.",fulltext,"Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis (CARE-MS) II, a 2-year randomized, rater-blinded, active-controlled, head-to-head, phase 3 trial, compared efficacy and safety of alemtuzumab 12 mg with subcutaneous interferon-β-1a (SC IFN-β-1a) 44 μg in patients with RRMS.",100.0
674,PRECIS-2,"Methods have been published elsewhere.12 CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).",fulltext,"Methods have been published elsewhere.12 CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 μg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).",100.0
674,PRECIS-2,Alemtuzumab-treated patients were more likely than SC IFN-β-1a–treated patients to show improvement in EDSS scores (p < 0.0001) on all 7 functional systems.,fulltext,Alemtuzumab-treated patients were more likely than SC IFN-β-1a–treated patients to show improvement in EDSS scores (p < 0.0001) on all 7 functional systems.,100.0
674,PRECIS-2,"In patients with RRMS and inadequate response to prior disease-modifying therapies, alemtuzumab provides greater benefits than SC IFN-β-1a across several disability outcomes, reflecting improvement of preexisting disabilities.",fulltext,"In patients with RRMS and inadequate response to prior disease-modifying therapies, alemtuzumab provides greater benefits than SC IFN-β-1a across several disability outcomes, reflecting improvement of preexisting disabilities.",100.0
675,PRECIS-2,"A total of 164 patients with MS referred themselves after having received information via the outpatient neurology clinic of the University Hospital Basel, other physicians, or advertisements posted in the Swiss Multiple Sclerosis Society Bulletin.",fulltext,"A total of 164 patients with MS referred themselves after having received information via the outpatient neurology clinic of the University Hospital Basel, other physicians, or advertisements posted in the Swiss Multiple Sclerosis Society Bulletin.",100.0
675,PRECIS-2,"All patients in the usual care (UC) group (and in the MBI group) received regular, currently optimal medical care during the duration of the study, as provided by the neurology department of the hospital. This included one medical examination at preintervention and another at 6 months postintervention, with additional measures as individually required.",fulltext,"All patients in the usual care (UC) group (and in the MBI group) received regular, currently optimal medical care during the duration of the study, as provided by the neurology department of the hospital. This included one medical examination at preintervention and another at 6 months postintervention, with additional measures as individually required.",100.0
675,PRECIS-2,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",fulltext,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",100.0
675,PRECIS-2,"Employing intention-to-treat analysis, MBI, compared with UC, improved nonphysical dimensions of primary outcomes at postintervention and follow-up (p < 0.002); effect sizes, 0.4–0.9 posttreatment and 0.3–0.5 at follow-up.",fulltext,"Employing intention-to-treat analysis, MBI, compared with UC, improved nonphysical dimensions of primary outcomes at postintervention and follow-up (p < 0.002); effect sizes, 0.4–0.9 posttreatment and 0.3–0.5 at follow-up.",100.0
675,PRECIS-2,"Assessments were made at baseline, postintervention, and 6 months follow-up.",fulltext,"Assessments were made at baseline, postintervention, and 6 months follow-up.",100.0
675,PRECIS-2,"MBI closely followed the program of mindfulness-based stress reduction23 and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10–15 participants/group; exercises did not exceed patients' level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.",fulltext,"MBI closely followed the program of mindfulness-based stress reduction23 and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10–15 participants/group; exercises did not exceed patients' level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.",100.0
675,PRECIS-2,"Excluded were patients with reported or medically recorded diagnoses of current serious psychological disorders other than depression and anxiety syndromes, evidence of dementia as indicated by testing below the fifth percentile in at least 3 of 6 dimensions of neuropsychological functioning (i.e., attention and concentration, processing speed, executive function, verbal memory, and verbal processing), other currently life-threatening or severely disabling physical disorders, current MS exacerbation, symptomatic MS medication altered in the last 3 months, other disorders of the CNS, pregnancy, or inability to speak or read German.",fulltext,"Excluded were patients with reported or medically recorded diagnoses of current serious psychological disorders other than depression and anxiety syndromes, evidence of dementia as indicated by testing below the fifth percentile in at least 3 of 6 dimensions of neuropsychological functioning (i.e., attention and concentration, processing speed, executive function, verbal memory, and verbal processing), other currently life-threatening or severely disabling physical disorders, current MS exacerbation, symptomatic MS medication altered in the last 3 months, other disorders of the CNS, pregnancy, or inability to speak or read German.",100.0
675,PRECIS-2,"Neurologists verified all patients for the following inclusion criteria: 1) diagnosis of relapsing-remitting (but no more than 2 exacerbations within the last year) or secondary progressive MS21 and 2) an Expanded Disability Status Scale (EDSS)22 score of ≤6 (no to moderately severe disability), with ≤1 step increase within the last year.",fulltext,"Neurologists verified all patients for the following inclusion criteria: 1) diagnosis of relapsing-remitting (but no more than 2 exacerbations within the last year) or secondary progressive MS21 and 2) an Expanded Disability Status Scale (EDSS)22 score of ≤6 (no to moderately severe disability), with ≤1 step increase within the last year.",100.0
677,PRECIS-2,"The main outcome measures used in the present study are in line with the international classification of functioning, disability, and health (ICF) model. The outcome measures on functioning level were: the Action Research Arm Test (ARA), Wolf Motor Function Test (WMFT), the Barthel Index (BI) and the Abilhand questionnaire. The disability outcome measure was: the Nine Hole Peg Test (NHPT) and the health outcome measure was the MOS 36-item short-form health survey (SF-36).",fulltext,"The outcome measures used in the present study are in line with the international classification of functioning, disability, and health (ICF) model. The outcome measures on functioning level were: the Action Research Arm Test (ARA), Wolf Motor Function Test (WMFT), the Barthel Index (BI) and the Abilhand questionnaire. The disability outcome measure was: the Nine Hole Peg Test (NHPT) and the health outcome measure was the MOS 36-item short-form health survey (SF-36).",98.94957983193278
677,PRECIS-2,"A total of 45 patients and 48 therapists responded to the user satisfaction questionnaire. In general, both patients and therapists were satisfied with the H-CAD system.",fulltext,"A total of 45 patients and 48 therapists responded to the user satisfaction questionnaire. In general, both patients and therapists were satisfied with the H-CAD system.",100.0
677,PRECIS-2,The included subjects received a baseline measurement (T0). The second measurement (T1) was performed after the month of usual care (for intervention as well as control group). The third measurement (T2) was performed after the month of H-CAD intervention for the intervention group and 2 months after baseline for the control group. A month after T2 a follow-up measurement was performed (T3) for the intervention group. The control group received their last measurement (T3) 4 months after baseline.,fulltext,The included subjects received a baseline measurement (T0). The second measurement (T1) was performed after the month of usual care (for intervention as well as control group). The third measurement (T2) was performed after the month of H-CAD intervention for the intervention group and 2 months after baseline for the control group. A month after T2 a follow up measurement was performed (T3) for the intervention group. The control group received their last measurement (T3) 4 months after baseline.,100.0
677,PRECIS-2,"The subjects were eligible for recruiting if they met the following criteria: (1) age > 18 years; (2) established diagnosis of the specific pathological condition MS, stroke or TBI; (3) nine hole peg test (NHPG) performed in more than 25 seconds; (4) ability to move at least one peg in 180 seconds during the NHPG; (5) sufficient autonomous functioning; (6) internet connection or telephone line and reachable internet provider; (7) clinical status stable; (8) discharged from hospital or rehabilitation setting – person lives at home.",fulltext,"The subjects were eligible for recruiting if they met the following criteria: (1) age > 18 years; (2) established diagnosis of the specific pathological condition MS, stroke or TBI; (3) nine hole peg test (NHPG) performed in more than 25 seconds; (4) ability to move at least one peg in 180 seconds during the NHPG; (5) sufficient autonomous functioning; (6) internet connection or telephone line and reachable internet provider; (7) clinical status stable; (8) discharged from hospital or rehabilitation setting – person lives at home.",100.0
677,PRECIS-2,"The subjects were recruited from Unità Organica di Riabilitazione Intensiva Neuromotoria (UORIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis Centre (NMSC, Belgium).",fulltext,"ents were recruited from Unità Organica di Riabilitazione Intensiva Neuromotoria (UORIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis Centre (NMSC, Belgium).",95.71428571428572
677,PRECIS-2,"The exercise compliance during treatment varied; the average days exercising with the system was 24 days (SD = 9, range 7-39 days).",fulltext,"The exercise compliance during treatment varied; the average days exercising with the system was 24 days (SD = 9, range 7-39 days).",100.0
677,PRECIS-2,"The tele-rehabilitation service is mainly addressed to neurological patients affected by traumatic brain injury (TBI), stroke or multiple sclerosis (MS).",fulltext,"The tele-rehabilitation service is mainly addressed to neurological patients affected by traumatic brain injury (TBI), stroke or multiple sclerosis (MS).",100.0
677,PRECIS-2,"The average scores – over all the time measurements – for the patients in the intervention group showed a slight improvement over time of the main outcome measures. However, statistical analysis revealed that these differences were not significant.",fulltext,"The average scores – over all the time measurements – for the patients in the intervention group showed a slight improvement over time of the main outcome measures. However, statistical analysis revealed that these differences were not significant.",100.0
677,PRECIS-2,The therapists completed a diary which contained the exercises performed by the patients and the received treatment.,fulltext,The therapists completed a diary which contained the exercises performed by the patients and the received treatment.,100.0
678,PRECIS-2,Patients in South East London who were severely affected by MS were referred by clinicians to the trial.,fulltext,Patients in South East London who were severely affected by MS were referred by clinicians to the trial.,100.0
678,PRECIS-2,"The PCT undertook assessments, suggested ways to improve physical, emotional, social, and other problems, provided specialist welfare benefits advice and bereavement support, and liaised with and acted as a catalyst for local services, both primary and specialist teams.",fulltext,"The PCT undertook assessments, suggested ways to improve physical, emotional, social, and other problems, provided specialist welfare benefits advice and bereavement support, and liaised with and acted as a catalyst for local services, both primary and specialist teams.",100.0
678,PRECIS-2,Educational seminars informed local health and social care professionals about the PCT.,fulltext,Educational seminars informed local health and social care professionals about the PCT.,100.0
678,PRECIS-2,"This comprised one part-time consultant in palliative medicine, one part-time clinical nurse specialist, one administrator, and one psychosocial worker, and was based in a large teaching hospital.",fulltext,"This comprised one part-time consultant in palliative medicine, one part-time clinical nurse specialist, one administrator, and one psychosocial worker, and was based in a large teaching hospital.",100.0
678,PRECIS-2,"Data were collected at baseline, 6, 12, 18, and 26 weeks on use of services, patient symptoms, other outcomes, and caregiver burden.",fulltext,"Data were collected at baseline, 6, 12, 18, and 26 weeks on use of services, patient symptoms, other outcomes, and caregiver burden.",100.0
678,PRECIS-2,"Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",fulltext,"Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",100.0
678,PRECIS-2,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.",fulltext,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.",100.0
678,PRECIS-2,"At 12 weeks, caregiver burden was 4.47 points lower (95% confidence interval [CI]: 1.05–7.89) in the fast track compared to the control group.",fulltext,"At 12 weeks, caregiver burden was 4.47 points lower (95% confidence interval [CI]: 1.05–7.89) in the fast track compared to the control group.",100.0
679,PRECIS-2,No safety concerns or adverse events were noted during the intervention.,fulltext,No safety concerns or adverse events were noted during the intervention.,100.0
679,PRECIS-2,"All endpoints were analyzed according to the intention-to-treat principle using an ANCOVA with the 6-month value as dependent variable, and condition, baseline value, disease duration and gender as independent variables.",fulltext,"All endpoints were analyzed according to the intention-to-treat principle using an ANCOVA with the 6-month value as dependent variable, and condition, baseline value, disease duration and gender as independent variables.",100.0
679,PRECIS-2,A total of 158 patients were screened for eligibility,fulltext, A total of 272 patients were screened for eligibilit,92.45283018867924
679,PRECIS-2,"CDT’s components are large group sessions, small group sessions, consultations (carrousel), a theatre evening, and start of the day with a joint activity (optional).",fulltext,"CDT’s components are large group sessions, small group sessions, consultations (carrousel), a theatre evening, and start of the day with a joint activity (optional).",100.0
679,PRECIS-2,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months.",fulltext,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months.",100.0
679,PRECIS-2,The enrolment started February 2013 and ended April 2016.,fulltext,The enrolment started February 2013 and ended April 2016.,100.0
679,PRECIS-2,"In a 6-month, single-centre, randomized (1:1), unmasked, controlled trial in RRMS patients with Expanded Disability Status Scale (EDSS) score ≤4.0",fulltext,"In a 6-month, single-centre, randomized (1:1), unmasked, controlled trial in RRMS patients with Expanded Disability Status Scale (EDSS) score ≤4.0",100.0
679,PRECIS-2,"Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands.",fulltext,"Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands.",100.0
679,PRECIS-2,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS.",fulltext,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS.",100.0
679,PRECIS-2,"Follow-up assessments were at one, three and six months.",fulltext,"Follow-up assessments were at one, three and six months.",100.0
680,PRECIS-2,"The CBT intervention consisted of 8 individual modules which focused on CBT based principles and strategies. These strategies included progressive muscle relaxation, controlled breathing exercises, pleasant activity scheduling, problem solving skills, cognitive exercises which helped individuals identify, challenge and manage unhelpful thoughts and beliefs.",fulltext,"The CBT intervention consisted of 8 individual modules which focused on CBT based principles and strategies. These strategies included progressive muscle relaxation, controlled breathing exercises, pleasant activity scheduling, problem solving skills, cognitive exercises which helped individuals identify, challenge and manage unhelpful thoughts and beliefs.",100.0
680,PRECIS-2,"Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",fulltext,"Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",100.0
680,PRECIS-2,"All participants completed the pre, post and 20 week follow up questionnaires.",fulltext,"All participants completed the pre, post and 20 week follow up questionnaires.",100.0
680,PRECIS-2,The tailored CBT intervention lends from Beck’s cognitive theoretical model for the treatment of depression in adults. Participants were given homework to complete for each of the 8 sessions. All sessions (apart from the first session which was 1.5 h) were 1 h in duration and took place in a clinic room at the hospital. A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.,fulltext,The tailored CBT intervention lends from Beck’s cognitive theoretical model for the treatment of depression in adults. Participants were given homework to complete for each of the 8 sessions. All sessions (apart from the first session which was 1.5 h) were 1 h in duration and took place in a clinic room at the hospital. A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.,100.0
680,PRECIS-2,The primary outcome was level of depressive symptoms at post and at 20 weeks follow up which was measured with the Beck Depression Inventory-II (BDI-II).,fulltext,The primary outcome was level of depressive symptoms at post and 3 month follow up which was measured with the Beck Depression Inventory-II (BDI-II) ,93.4640522875817
680,PRECIS-2,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.,fulltext,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.,100.0
680,PRECIS-2,"Results of ANCOVAs examining group differences on primary and secondary variables at pre, post and 20 week follow up are presented in Table 2.",fulltext,"Results of ANCOVAs examining group differences on primary and secondary variables at pre, post and 20 week follow up are presented in Table 2.",100.0
680,PRECIS-2,"The study took place at a large teaching and research hospital in Melbourne, Australia.",fulltext,"The study took place at a large teaching and research hospital in Melbourne, Australia.",100.0
681,PRECIS-2,"Participants were recruited from this register. Participants had a confirmed diagnosis of multiple sclerosis, an Extended Disability Status Scale33 score of 5 (ambulatory without aid or rest for about 200 m) to 6.5 (constant bilateral assistance required to walk about 20 m without resting), stable rehabilitation and drug therapy for 30 days before entry into the study, cognitive scores of over 24 on the Mini-Mental State Examination34 and access to the intervention sites using their own or public transport.",fulltext,"Participants were recruited from this register. Participants had a confirmed diagnosis of multiple sclerosis, an Extended Disability Status Scale33 score of 5 (ambulatory without aid or rest for about 200 m) to 6.5 (constant bilateral assistance required to walk about 20 m without resting), stable rehabilitation and drug therapy for 30 days before entry into the study, cognitive scores of over 24 on the Mini-Mental State Examination34 and access to the intervention sites using their own or public transport.",100.0
681,PRECIS-2,"Data were analysed using a univariate general linear model analysis of variance (ANOVA) which allowed for missing data, possible differences over time (baseline, week 8 and week 12) and possible differences between groups (intervention and control) to be assessed.",fulltext,"Data were analysed using a univariate general linear model analysis of variance (ANOVA) which allowed for missing data, possible differences over time (baseline, week 8 and week 12) and possible differences between groups (intervention and control) to be assessed.",100.0
681,PRECIS-2,"Outcome measures were carried out within the local hospital’s rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",fulltext,"Outcome measures were carried out within the local hospital’s rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",100.0
681,PRECIS-2,The intervention took place at two different geographical locations (Site A and Site B).,fulltext,The intervention took place at two different geographical locations (Site A and Site B).,100.0
681,PRECIS-2,"For the primary outcome measure, the Timed 25-Foot Walk Test, the ANOVA results demonstrated no statistically significant difference over time.",fulltext,"For the primary outcome measure, the Timed 25-Foot Walk Test, the ANOVA results demonstrated no statistically significant difference over time.",100.0
681,PRECIS-2,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets. Forty-three potential participants expressed an interest in participating.,fulltext,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets. Forty-three potential participants expressed an interest in participating.,100.0
681,PRECIS-2,"Participants assigned to the intervention group attended a leisure centre-based exercise class, twice weekly for 12 weeks. Each group was led by two instructors (one physiotherapist and one fitness instructor).",fulltext,"Participants assigned to the intervention group attended a leisure centre-based exercise class, twice weekly for 12 weeks. Each group was led by two instructors (one physiotherapist and one fitness instructor).",100.0
681,PRECIS-2,"Participants completed a circuit of 8–12 different exercises for 1 minute each, having a rest (of a minimum of 1 minute) before moving to the next exercise. Not all exercises were performed at all classes, and in week 9 a fifth level of difficulty was added to some of the exercises to encourage progress.",fulltext,"Participants completed a circuit of 8–12 different exercises for 1 minute each, having a rest (of a minimum of 1 minute) before moving to the next exercise. Not all exercises were performed at all classes, and in week 9 a fifth level of difficulty was added to some of the exercises to encourage progress.",100.0
681,PRECIS-2,"Participants assigned to the control group were advised to continue their usual routine, seeking any healthcare as required. They were asked to avoid beginning any new exercise regime for the 12 weeks of the study.",fulltext,"Participants assigned to the control group were advised to continue their usual routine, seeking any healthcare as required. They were asked to avoid beginning any new exercise regime for the 12 weeks of the study.",100.0
684,PRECIS-2,All outcome variables were summarized and comparisons made between groups and over time.,fulltext,All outcome variables were summarized and comparisons made between groups and over time.,100.0
684,PRECIS-2,"A total of 91 people were contacted, 41 agreed to participate and were screened.",fulltext,"A total of 91 people were contacted, 41 agreed to participate and were screened.",100.0
684,PRECIS-2,"Subjects assigned to Group 1 received physio- therapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home.",fulltext,"Subjects assigned to Group 1 received physio- therapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home.",100.0
684,PRECIS-2,"Each session lasted up to 60 min- utes, and a task-speciﬁc programme included upper and lower limb strengthening using thera- band, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit ﬁts) and stretching activities were used depending on the subjects previously identiﬁed goals. Each subject therefore received core treatments aimed to maximize strength, ﬂexibility and function.",fulltext,"Each session lasted up to 60 min- utes, and a task-speciﬁc programme included upper and lower limb strengthening using thera- band, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit ﬁts) and stretching activities were used depending on the subjects previously identiﬁed goals. Each subject therefore received core treatments aimed to maximize strength, ﬂexibility and function.",100.0
684,PRECIS-2,Community; subjects’ homes.,fulltext,Community; subjects’ homes.,100.0
684,PRECIS-2,"Subjects had a deﬁnite diag- nosis of primary or secondary progressive MS, and an EDSS of between 6.5 (constant bilateral assistance required to walk about 20 metres with- out resting) to 8 (essentially restricted to bed or chair or perambulated in wheelchair, but may be out of bed much of the day, retains many self- care functions and generally has eﬀective use of arms).",fulltext,"Subjects had a deﬁnite diag- nosis of primary or secondary progressive MS, and an EDSS of between 6.5 (constant bilateral assistance required to walk about 20 metres with- out resting) to 8 (essentially restricted to bed or chair or perambulated in wheelchair, but may be out of bed much of the day, retains many self- care functions and generally has eﬀective use of arms).",100.0
684,PRECIS-2,Subjects in both groups were assessed at the beginning and at the end of the eight-week inter- vention period (i.e. either physiotherapy or con- trol) and then again eight weeks later.,fulltext,Subjects in both groups were assessed at the beginning and at the end of the eight-week inter- vention period (i.e. either physiotherapy or con- trol) and then again eight weeks later.,100.0
684,PRECIS-2,None of the control group received physiotherapy treat- ment during the intervention period.,fulltext,None of the control group received physiotherapy treat- ment during the intervention period.,100.0
684,PRECIS-2,"The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS,12 was the primary outcome measure for the study.",fulltext,"The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS,12 was the primary outcome measure for the study.",100.0
685,PRECIS-2,The only selection criterion was that the diagnosis of MS was confirmed by the general practitioner. There were no exclusion criteria.,fulltext,The only selection criterion was that the diagnosis of MS was confirmed by the general practitioner. There were no exclusion criteria.,100.0
685,PRECIS-2,"The intervention group were less likely to consider help with activities of daily living to be essential, and were more likely to experience better vitality and mental health than the control group at follow-up.",fulltext,"The intervention group were less likely to consider help with activities of daily living to be essential, and were more likely to experience better vitality and mental health than the control group at follow-up.",100.0
685,PRECIS-2,"Main outcome measures: These included the Barthel Index, a measure of mobility, the SF-36, and the Standard Day Dependency Record (SDDR) which measures the need for assistance with daily activities.",fulltext,"Main outcome measures: These included the Barthel Index, a measure of mobility, the SF-36, and the Standard Day Dependency Record (SDDR) which measures the need for assistance with daily activities.",100.0
685,PRECIS-2,The study was conducted with people with MS living in the community.,fulltext,The study was conducted with people with MS living in the community.,100.0
685,PRECIS-2,Participants: Two hundred and seventy-eight people with MS were invited to take part in the study. One hundred and eighty-nine people consented to take part (68%). Of these 183 began the study and 169 (92.3%) completed it.,fulltext,Participants: Two hundred and seventy-eight people with MS were invited to take part in the study. One hundred and eighty-nine people consented to take part (68%). Of these 183 began the study and 169 (92.3%) completed it.,100.0
685,PRECIS-2,Follow-up assessments were conducted six months after baseline.,fulltext,Follow-up assessments were conducted six months after baseline.,100.0
685,PRECIS-2,The self-care programme primarily comprised a discussion of self-care strategies supported by an information booklet developed for the study in line with consumer priorities.,fulltext,The self-care programme primarily comprised a discussion of self-care strategies supported by an information booklet developed for the study in line with consumer priorities.,100.0
685,PRECIS-2,"Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West London and in counties contiguous with Greater London.",fulltext,"Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West London and in counties contiguous with Greater London.",100.0
685,PRECIS-2,Missing values on scales were replaced with group means for each outcome measure.,fulltext,Missing values on scales were replaced with group means for each outcome measure.,100.0
686,PRECIS-2,"For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a maximum three-month period after inclusion.",fulltext,"For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a maximum three-month period after inclusion.",100.0
686,PRECIS-2,"Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.",fulltext,"Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.",100.0
686,PRECIS-2,Signed informed consent was obtained for each patient at inclusion.,fulltext,Signed informed consent was obtained for each patient at inclusion.,100.0
686,PRECIS-2,MS patients from the outpatient clinic of the Neurology Department of Pitié-Salpêtrière Hospital were prospectively enrolled in the study between March 2010 and July 2012.,fulltext,MS patients from the outpatient clinic of the Neurology Department of Pitié-Salpêtrière Hospital were prospectively enrolled in the study between March 2010 and July 2012.,100.0
686,PRECIS-2,"The primary outcome was the change in QoL from inclusion to M6, assessed by the Multiple Sclerosis Impact Scale (MSIS-29) self-questionnaire.",fulltext,"The primary outcome was the change in QoL from inclusion to M6, assessed by the Multiple Sclerosis Impact Scale (MSIS-29) self-questionnaire.",100.0
686,PRECIS-2,"All analyses were performed with the SAS software version 9.2 (SAS Institute, Cary, NC, USA).",fulltext,"All analyses were performed with the SAS software version 9.2 (SAS Institute, Cary, NC, USA).",100.0
686,PRECIS-2,"Depending on their needs, evaluated during the inclusion visit and re-evaluated during the multidisciplinary visit, patients were seen by different MS specialists and allied health professionals.",fulltext,"Depending on their needs, evaluated during the inclusion visit and re-evaluated during the multidisciplinary visit, patients were seen by different MS specialists and allied health professionals.",100.0
686,PRECIS-2,"Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neuro-urology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsychologist).",fulltext,"Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neuro-urology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsychologist).",100.0
686,PRECIS-2,"The study protocol was approved by the coordinator of our local (Pitié-Salpêtrière Hospital) ethics committee, and formal review by the committee was judged unnecessary.",fulltext,"The study protocol was approved by the coordinator of our local (Pitié-Salpêtrière Hospital) ethics committee, and formal review by the committee was judged unnecessary.",100.0
686,PRECIS-2,"This is a prospective, randomized, controlled, monocentric clinical trial in MS patients.",fulltext,"This is a prospective, randomized, controlled, monocentric clinical trial in MS patients.",100.0
687,PRECIS-2,"The website, which was used to deliver the intervention, was developed in collaboration with a patient steering group and incorporating recommendations from the MS Society accessibility policy and advice from the Scottish Accessible Information Forum.",fulltext,"The website, which was used to deliver the intervention, was developed in collaboration with a patient steering group and incorporating recommendations from the MS Society accessibility policy and advice from the Scottish Accessible Information Forum.",100.0
687,PRECIS-2,Rehabilitation centre and participants’ homes.,fulltext,Rehabilitation centre and participants’ homes.,100.0
687,PRECIS-2,"Participants were given unique log-in details to view their own, online personalised exercise programme. This was a pragmatic study with the content of the web-based programme being similar to the content if it had been delivered face-to-face.",fulltext,"Participants were given unique log-in details to view their own, online personalised exercise programme. This was a pragmatic study with the content of the web-based programme being similar to the content if it had been delivered face-to-face.",100.0
687,PRECIS-2,Outcome measures were recorded at baseline and at the end of the intervention period (week 13).,fulltext,Outcome measures were recorded at baseline and at the end of the intervention period (week 13).,100.0
687,PRECIS-2,"Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate.",fulltext,"Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate.",100.0
687,PRECIS-2,Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist.,fulltext,Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist.,100.0
687,PRECIS-2,All analysis was performed on SPSS v20 with power calculations for a future fully powered trial being estimated using nQuery v7.,fulltext,All analysis was performed on SPSS v20 with power calculations for a future fully powered trial being estimated using nQuery v7.,100.0
687,PRECIS-2,Thirty community dwelling adults moderately affected by MS (Expanded Disability Status Scale 5-6.5).,fulltext,Thirty community dwelling adults moderately affected by MS (Expanded Disability Status Scale 5-6.5).,100.0
687,PRECIS-2,"The primary outcome measure, the timed 25ft walk,14 has good reliability and validity in the MS population.",fulltext,"The primary outcome measure, the timed 25 foot walk,14 has good reliability and validity in the MS population.",100.0
688,PRECIS-2,"To be eligible, all patients screened for study participation had to be affected by clinically definite multiple sclerosis and live in the Rome service area.",fulltext,"To be eligible, all patients screened for study participation had to be affected by clinically definite multiple sclerosis17 and live in the Rome service area.",100.0
688,PRECIS-2,"At the end of a one year follow up period, all patients underwent the same comprehensive interview as at baseline.",fulltext,"At the end of a one year follow up period, all patients underwent the same comprehensive interview as at baseline.",100.0
688,PRECIS-2,"Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",fulltext,"Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",100.0
688,PRECIS-2,Patients were randomised in a ratio 2:1 to an intervention group (133) or a control group (68).,fulltext, were randomised in a ratio 2:1 to an intervention group (133) or a control group (68).,91.57894736842105
688,PRECIS-2,Patients could be admitted to the scheme only if they agreed to be randomised.,fulltext,Patients could be admitted to the scheme only if they agreed to be randomised.,100.0
688,PRECIS-2,Patients could be admitted to the scheme only if they agreed to be randomized.,fulltext, patients could be admitted to the scheme only if they agreed to be randomised,97.43589743589743
688,PRECIS-2,The type of care was more than is normally available in the community through National Health Service care.,fulltext,The type of care was more than is normally available in the community through National Health Service care.,100.0
688,PRECIS-2,"Based on individual needs, patients randomized to home-based care were followed through home visits and telephone follow-up.",fulltext,"Based on individual needs, patients randomised to home based care were followed through home visits and telephone follow up.",99.19354838709677
688,PRECIS-2,"The home-based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physician, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator.",fulltext,"The home based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physician, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator.",100.0
688,PRECIS-2,"Baseline data for both groups were collected after randomization, using standardized instruments.",fulltext," were collected after randomisation, using standardised instruments.",68.04123711340206
688,PRECIS-2,"The multidisciplinary team collaborated with the patient, physician, and caregiver in designing individualized clinical care and in coordinating home services as appropriate for the individual patient.",fulltext,"The multidisciplinary team collaborated with the patient, physician, and caregiver in designing individualised clinical care and in coordinating home services as appropriate for the individual patient.",99.50248756218906
688,PRECIS-2,"For each scale of the SF-36 and separately for the case and control group, we adopted a regression model in which score changes at the end of the follow-up period were adjusted for the baseline values.",fulltext,"For each scale of the SF-36 and separately for the case and control group, we adopted a regression model in which score changes at the end of the follow-up period were adjusted for the baseline values.",100.0
688,PRECIS-2,"The majority of refusers (n = 62) were young, fully ambulant, and employed. They were uncertain that home based management could be adopted in their situations.",fulltext,"The majority of refusers (n = 62) were young, fully ambulant, and employed. They were uncertain that home based management could be adopted in their situations.",100.0
688,PRECIS-2,They were assessed at baseline and one year after randomization with validated measures of physical and psychological impairment and quality of life.,fulltext,They were assessed at baseline and one year after randomisation with validated measures of physical and psychological impairment and quality of life ,99.32885906040269
688,PRECIS-2,The study was conducted in Rome.,fulltext,The study was conducted in Rome.,100.0
689,PRECIS-2,Eighty-five participants met the criteria for inclusion and consented to participate in the study between September 2014 and January 2017.,fulltext,Eighty-five participants met the criteria for inclusion and consented to participate in the study between September 2014 and January 2017.,100.0
689,PRECIS-2,"Assessed at 0, 3, 6 and 12 months.",fulltext,"Assessed at 0, 3, 6 and 12 months.",100.0
689,PRECIS-2,Seven Multiple Sclerosis outpatient centres across Scotland.,fulltext,Seven Multiple Sclerosis outpatient centres across Scotland.,100.0
689,PRECIS-2,"Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet. Potential participants contacted the researchers if they were interested in participating.",fulltext,"Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet. Potential participants contacted the researchers if they were interested in participating.",100.0
689,PRECIS-2,No information provided.,fulltext,nt Information Services ,79.16666666666666
689,PRECIS-2,A Restricted Maximum Likelihood approach to fitting mixed models was employed to allow intention to treat assumptions to cope with missing data.,fulltext,A Restricted Maximum Likelihood approach to fitting mixed models was employed to allow intention to treat assumptions to cope with missing data.,100.0
689,PRECIS-2,"Participants randomized to the usual care group were fitted with a custom-made, solid, ankle-foot orthosis by an orthotist, within four weeks of their initial assessment.",fulltext,"Participants randomized to the usual care group were fitted with a custom-made, solid, ankle-foot orthosis by an orthotist, within four weeks of their initial assessment.",100.0
689,PRECIS-2,Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,fulltext,Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,100.0
689,PRECIS-2,"Participants required to have a clinical diagnosis of Multiple Sclerosis, persistent foot drop (lasting a minimum of three months) observed during a 5-minute walk test, stable disease (no change in the Extended Disability Status Score12 or relapse in previous three months), 5° of passive dorsiflexion and tolerance of functional electrical stimulation. Participants were excluded if they had previously used functional electrical stimulation or an ankle-foot orthosis for foot drop, moderate to severe cognitive impairment (scored < 26, Montreal Cognitive Assessment),13 foot drop due to other disorders, other conditions significantly affecting gait, contraindications to functional electrical stimulation, marked proximal weakness, plantar flexor spasticity, stance phase instability or severe lower limb/trunk ataxia affecting gait.",fulltext,"Participants required to have a clinical diagnosis of Multiple Sclerosis, persistent foot drop (lasting a minimum of three months) observed during a 5-minute walk test, stable disease (no change in the Extended Disability Status Score12 or relapse in previous three months), 5° of passive dorsiflexion and tolerance of functional electrical stimulation. Participants were excluded if they had previously used functional electrical stimulation or an ankle-foot orthosis for foot drop, moderate to severe cognitive impairment (scored < 26, Montreal Cognitive Assessment),13 foot drop due to other disorders, other conditions significantly affecting gait, contraindications to functional electrical stimulation, marked proximal weakness, plantar flexor spasticity, stance phase instability or severe lower limb/trunk ataxia affecting gait.",100.0
689,PRECIS-2,Walking speed as measured by the 5-minute self-selected walk test.,fulltext,Walking speed as measured by the 5-minute self-selected walk test.,100.0
690,PRECIS-2,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician (the intervention was not intended to replace existing services).",fulltext,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician (the intervention was not intended to replace existing services).",100.0
690,PRECIS-2,"In this randomized, examiner-blind, controlled study, we recruited patients from three Italian centers.",fulltext,"In this randomized, examiner-blind, controlled study, we recruited patients from three Italian centers.",100.0
690,PRECIS-2,"Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers. Other patient inclusion criteria were primary or secondary progressive MS,1,13 Expanded Disability Status Scale (EDSS) score ⩾ 8.0,14 complex symptoms,15 and ⩾2 unmet care needs.16 The carer (a family member, relative, or friend of the patient) was his or her next of kin and was designated by the patient except for patients with severe cognitive compromise.",fulltext,"Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers. Other patient inclusion criteria were primary or secondary progressive MS,1,13 Expanded Disability Status Scale (EDSS) score ⩾ 8.0,14 complex symptoms,15 and ⩾2 unmet care needs.16 The carer (a family member, relative, or friend of the patient) was his or her next of kin and was designated by the patient except for patients with severe cognitive compromise.",100.0
690,PRECIS-2,"Based on the principles of PC,17 each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker.",fulltext,"Based on the principles of PC,17 each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker.",100.0
690,PRECIS-2,"All randomly assigned patients were included in the main intention-to-treat analysis, provided that at least one contact with the team occurred (HPA group).",fulltext,"All randomly assigned patients were included in the main intention-to-treat analysis, provided that at least one contact with the team occurred (HPA group).",100.0
690,PRECIS-2,Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers.,fulltext,Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers.,100.0
690,PRECIS-2,"In the event of emergencies, dyads contacted the patient caring physician or emergency medical services.",fulltext,"In the event of emergencies, dyads contacted the patient caring physician or emergency medical services.",100.0
690,PRECIS-2,"Primary outcome measures were Palliative care Outcome Scale-Symptoms-MS (POS-S-MS) and Schedule for the Evaluation of Individual Quality of Life-Direct Weighting (SEIQoL-DW, not assessed in severely cognitively compromised patients).",fulltext,"Primary outcome measures were Palliative care Outcome Scale-Symptoms-MS (POS-S-MS) and Schedule for the Evaluation of Individual Quality of Life-Direct Weighting (SEIQoL-DW, not assessed in severely cognitively compromised patients).",100.0
690,PRECIS-2,"A blind examiner assessed dyads at baseline, 3 months, and 6 months.",fulltext,"A blind examiner assessed dyads at baseline, 3 months, and 6 months.",100.0
691,PRECIS-2,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4)16 and (3) ambulatory. The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.",fulltext,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4)16 and (3) ambulatory. The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.",100.0
691,PRECIS-2,Participants receiving the intervention continued to have access to services available as part of their usual local care.,fulltext,Participants receiving the intervention continued to have access to services available as part of their usual local care.,100.0
691,PRECIS-2,The main analysis was intention-to-treat but we also conducted a ‘per protocol’ analysis (excluding participants who attended fewer than four FACETS sessions).,fulltext,The main analysis was intention-to-treat but we also conducted a ‘per protocol’ analysis (excluding participants who attended fewer than four FACETS sessions).,100.0
691,PRECIS-2,Facilitators were all qualified to a senior/advanced level (in the UK minimum of a Band 7 on the NHS Agenda for Change (AfC) grading structure).17 Facilitators were trained to deliver the intervention at 1-day workshops and psychological advice and debriefing were available for facilitators throughout the trial.,fulltext,Facilitators were all qualified to a senior/advanced level (in the UK minimum of a Band 7 on the NHS Agenda for Change (AfC) grading structure).17 Facilitators were trained to deliver the intervention at 1-day workshops and psychological advice and debriefing were available for facilitators throughout the trial.,100.0
691,PRECIS-2,"FACETS was delivered in hotel meeting-room facilities, with the exception of one centre, where it was held in a rehabilitation hospital.",fulltext,"FACETS was delivered in hotel meeting-room facilities, with the exception of one centre, where it was held in a rehabilitation hospital.",100.0
691,PRECIS-2,"For those allocated to the FACETS arm, outcomes were measured 1 week (baseline) before the start of FACETS and 1 month (follow-up 1) and 4 months (follow-up 2) after the final session.",fulltext,"For those allocated to the FACETS arm, outcomes were measured 1 week (baseline) before the start of FACETS and 1 month (follow-up 1) and 4 months (follow-up 2) after the final session.",100.0
691,PRECIS-2,There were statistically significantly greater improvements in fatigue self-efficacy in the FACETS arm at follow-up 1 and 2 compared with the CLP arm.,fulltext,There were statistically significantly greater improvements in fatigue self-efficacy in the FACETS arm at follow-up 1 and 2 compared with the CLP arm.,100.0
691,PRECIS-2,"The manualised group-based FACETS programme is described elsewhere13 and is based upon a conceptual framework integrating elements from cognitive behavioural, social-cognitive, energy effectiveness, self-management and self-efficacy theories.",fulltext,"The manualised group-based FACETS programme is described elsewhere13 and is based upon a conceptual framework integrating elements from cognitive behavioural, social-cognitive, energy effectiveness, self-management and self-efficacy theories.",100.0
691,PRECIS-2,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",fulltext,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",100.0
692,PRECIS-2,"We excluded those who were receiving drug treatment for fatigue started less than three months ago or acute hospital or nursing home, those who were having psychiatric disorders.",fulltext,"We excluded those who were receiving drug treatment for fatigue started less than three months ago or acute hospital or nursing home, those who were having psychiatric disorders.",100.0
692,PRECIS-2,The PA program was delivered by a neurologist and a specialist in physical medicine and rehabilitation.,fulltext,"the same PA program, which was controlled for contraindications and delivered by a neurologist (OH) at Poissy CHI Hospital (France) and a specialist in physical medicine and rehabilitation ",100.0
692,PRECIS-2,The Wilcoxon signed rank test showed a statistically significant difference in change scores across the three groups for the MSIS-29 physical component.,fulltext,The Wilcoxon signed rank test showed a statistically significant difference in change scores across the three groups for the MSIS-29 physical component.,100.0
692,PRECIS-2,Participants were approached by the study coordinator and asked if they would be willing to participate in it.,fulltext,ividuals were approached by the study coordinator and asked if they would be willing to participate in it.,92.72727272727272
692,PRECIS-2,The PA program was manualized and available as a booklet.,fulltext,The PA program was manualized and available as a booklet.,100.0
692,PRECIS-2,"Participants in the control group were not guided to develop if-then plans and they did not receive any mindfulness training, however, they received the same PA program over a period of eight weeks.",fulltext,"Participants in the control group were not guided to develop if-then plans and they did not receive any mindfulness training, however, they received the same PA program over a period of eight weeks.",100.0
692,PRECIS-2,"The primary outcomes, fatigue, mobility, and quality of life, were examined at baseline prior to randomization, and then 8-weeks after the intervention (following the online intervention).",fulltext,"The primary outcomes, fatigue, mobility and quality of life, were examined at baseline prior to randomization, and then 8-weeks after the intervention (following the online intervention).",99.46808510638297
692,PRECIS-2,Participants were asked to develop a concrete if-then plan (the “if” component followed by the “then” component) once a week and share them through TailorBuilder app.,fulltext,Participants were asked to develop a concrete if-then plan (the “if” component followed by the “then” component) once a week and share them through TailorBuilder app.,100.0
692,PRECIS-2,"This clinical and multicentric trial took place from July 2017 to January 2020, in two hospitals in the Parisian Region, France (Hospitals – CHI Poissy St Germain-en-Laye and R. Poincaré, Garches).",fulltext,"This clinical and multicentric trial took place from July 2017 to January 2020, in two hospitals in the Parisian Region, France (Hospitals – CHI Poissy St Germain-en-Laye and R. Poincaré, Garches).",100.0
692,PRECIS-2,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",fulltext,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",100.0
692,PRECIS-2,"Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French.",fulltext,"Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French.",100.0
693,PRECIS-2,The participants were randomly divided into SC and yoga group.,fulltext,The participants were randomly divided into SC and yoga group.,100.0
693,PRECIS-2,The climbing wall with an inclination of 90° and the height of 5 m was adjusted for patients with physical disabilities by adding numerous and bigger holds.,fulltext,The climbing wall with an inclination of 90° and the height of 5 m was adjusted for patients with physical disabilities by adding numerous and bigger holds.,100.0
693,PRECIS-2,"Data were analyzed by SPSS program for Windows®, version 17.0. Wilcoxon signed ranks test was used to compare the difference before and after each program.",fulltext,"Data were analyzed by SPSS program for Windows®, version 17.0. Wilcoxon signed ranks test was used to compare the difference before and after each program.",100.0
693,PRECIS-2,"20 subjects with relapsing–remitting or progressive MS, 26–50 years of age, with EDSS ≤ 6 and EDSS pyramidal functions score (EDSSpyr) > 2 were enrolled in a randomized prospective study.",fulltext,"20 subjects with relapsing–remitting or progressive MS, 26–50 years of age, with EDSS ≤ 6 and EDSS pyramidal functions score (EDSSpyr) > 2 were enrolled in a randomized prospective study.",100.0
693,PRECIS-2,"SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License.",fulltext,"SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License.",100.0
693,PRECIS-2,"All patients were belayed with the “top rope” system, which provided a safe climbing opportunity with the possibility to rest in the wall at any point.",fulltext,"All patients were belayed with the “top rope” system, which provided a safe climbing opportunity with the possibility to rest in the wall at any point.",100.0
693,PRECIS-2,Both programs were held once a week for 10 weeks.,fulltext,Both programs were held once a week for 10 weeks.,100.0
693,PRECIS-2,There were no significant improvements in spasticity after SC and yoga.,fulltext,There were no significant improvements in spasticity after SC and yoga.,100.0
693,PRECIS-2,top rope,fulltext,top rope,100.0
694,PRECIS-2,A planned start of treatment with new anti-spastic drugs or other medications that may have an influence on the assessed outcomes also resulted in exclusion.,fulltext,A planned start of treatment with new anti-spastic drugs or other medications that may have an influence on the assessed outcomes also resulted in exclusion.,100.0
694,PRECIS-2,"Patients in the control group continued their previous therapy. Over the study period, symptomatic drug treatment, immunotherapy, and physiotherapy were kept unchanged in both groups.",fulltext,"Patients in the control group continued their previous therapy. Over the study period, symptomatic drug treatment, immunotherapy, and physiotherapy were kept unchanged in both groups.",100.0
694,PRECIS-2,MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) between 4 and 6.5 were eligible for inclusion.,fulltext,MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS)9 score between 4 and 6.5 were eligible for inclusion.,100.0
694,PRECIS-2,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment).",fulltext,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment).",100.0
694,PRECIS-2,Primary outcome was the change in the Berg Balance Scale (BBS) after 12 weeks.,fulltext,Primary outcome was the change in the Berg Balance Scale (BBS) after 12 weeks.,100.0
694,PRECIS-2,Analyses were based on the modified intention-to-treat set (modified ITT). This set encompasses all randomized patients with valid baseline assessment.,fulltext,Analyses were based on the modified intention-to-treat set (modified ITT). This set encompasses all randomized patients with valid baseline assessment.,100.0
694,PRECIS-2,"Patients of the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) once a week for 12 weeks as an add-on therapy to their standard care, which remained unchanged.",fulltext,"Patients of the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR))8 once a week for 12 weeks as an add-on therapy to their standard care, which remained unchanged.",100.0
694,PRECIS-2,"Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.",fulltext,"Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.",100.0
694,PRECIS-2,"The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.",fulltext,"The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.",100.0
694,PRECIS-2,A total of 70 adults with MS were recruited in five German centers and randomly allocated to the intervention group (12 weeks of hippotherapy) or the control group.,fulltext,A total of 70 adults with MS were recruited in five German centers and randomly allocated to the intervention group (12 weeks of hippotherapy) or the control group.,100.0
695,PRECIS-2,Setting: Participants' homes in the City of Nottingham.,fulltext,Setting: Participants' homes in the City of Nottingham.,100.0
695,PRECIS-2,Participants could have been disadvantaged by the lack of a professional mentor to support actions prompted by the educational intervention. There is ample evidence that professionally mediated assessments and interventions can reduce the frequency of falls.,fulltext,Participants could have been disadvantaged by the lack of a professional mentor to support actions prompted by the educational intervention. There is ample evidence that professionally mediated assessments and interventions can reduce the frequency of falls.,100.0
695,PRECIS-2,"There was no difference between CoG and EG in the Nottingham Extended Activities of Daily Living score, but EG patients showed a significant rise in this score over the study period.",fulltext,"There was no difference between CoG and EG in the Nottingham Extended Activities of Daily Living score, but EG patients showed a significant rise in this score over the study period.",100.0
695,PRECIS-2,The EG reported significantly more falls during the follow-up period and at 12 months,fulltext,The EG reported significantly more falls during the follow-up period and at 12 months,100.0
695,PRECIS-2,"From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282000). Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",fulltext,"From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282000). Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",100.0
695,PRECIS-2,The concept of the expert patient arises from the demand for information to assist people in their self-management of chronic diseases. There is some evidence that education can benefit people with non-neurological conditions and with progressive neurological conditions.,fulltext,The concept of the expert patient arises from the demand for information to assist people in their self-management of chronic diseases.8 There is some evidence that education can benefit people with non-neurological conditions8- and with progressive neurological conditions.,100.0
695,PRECIS-2,"Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",fulltext,"Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",100.0
695,PRECIS-2,"Participants: One hundred and fourteen people with progressive neurological conditions recruited from general practices in Nottingham, including 53 with Parkinson's disease and 45 with multiple sclerosis",fulltext,"Participants: One hundred and fourteen people with progressive neurological conditions recruited from general practices in Nottingham, including 53 with Parkinson's disease and 45 with multiple sclerosis",100.0
695,PRECIS-2,To test the effects of a home-based educational intervention in reducing the incidence and the risk of falls and pressure sores in adults with progressive neurological conditions.,fulltext,To test the effects of a home-based educational intervention in reducing the incidence and the risk of falls and pressure sores in adults with progressive neurological conditions.,100.0
695,PRECIS-2,Participants were assessed at baseline and 12 months later.,fulltext,Participants were assessed at baseline and 12 months later.,100.0
695,PRECIS-2,"In the education group (EG), baseline data were reviewed by an expert panel which advised on actions most likely to promote each individual's physical, social and psychological well-being. An occupational therapist (OT) then visited EG participants to provide education and information and to discuss a personalized 12-month health action plan.",fulltext,"In the education group (EG), baseline data were reviewed by an expert panel which advised on actions most likely to promote each individual's physical, social and psychological well-being. An occupational therapist (OT) then visited EG participants to provide education and information and to discuss a personalized 12-month health action plan.",100.0
696,PRECIS-2,"A physical examination and neurological assessment was administered at baseline, 3, 6 and 12 months postdiscontinuation (counted from the last natalizumab infusion), as well as during unscheduled visits due to relapses (within 3–5 days of any new symptom development).",fulltext,"A physical examination and neurological assessment was administered at baseline, 3, 6 and 12 months postdiscontinuation (counted from the last natalizumab infusion), as well as during unscheduled visits due to relapses (within 3–5 days of any new symptom development).",100.0
696,PRECIS-2,Fifty relapsing patients with multiple sclerosis (MS) who had been on natalizumab therapy ≥24 months and were contemplating natalizumab discontinuation were enrolled.,fulltext,Fifty relapsing patients with multiple sclerosis (MS) who had been on natalizumab therapy ≥24 months and were contemplating natalizumab discontinuation were enrolled.,100.0
696,PRECIS-2,"This was a prospective, phase IV, 12-month, open-label, single center single-blinded (MRI) randomised study.",fulltext,"This was a prospective, phase IV, 12-month, open-label, single center single-blinded (MRI) randomised study.",100.0
696,PRECIS-2,Patients in both groups may have received additional optional treatment with intravenous myethylprednisolone (IVMP) in the first 6 months post-natalizumab discontinuation.,fulltext,Patients in both groups may have received additional optional treatment with intravenous myethylprednisolone (IVMP) in the first 6 months post-natalizumab discontinuation.,100.0
696,PRECIS-2,"Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria,19 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.",fulltext,"Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria,19 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.",100.0
696,PRECIS-2,"To compare two modes of natalizumab cessation interventions: immediate versus tapered down, as measured by serial MRI and the occurrence of relapses during a 12-month period.",fulltext,"To compare two modes of natalizumab cessation interventions: immediate versus tapered down, as measured by serial MRI and the occurrence of relapses during a 12-month period.",100.0
696,PRECIS-2,Candidates were excluded from the study if active disease was identified at baseline per clinical (presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).,fulltext,Candidates were excluded from the study if active disease was identified at baseline per clinical (presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).,100.0
696,PRECIS-2,No information provided in the full text.,prompt,ed on the full text ,46.34146341463414
697,PRECIS-2,The group program was conducted at a local community center and included four to six participants per class.,fulltext,The group program was conducted at a local community center and included four to six participants per class.,100.0
697,PRECIS-2,"The group program was conducted at a local community center and included four to six participants per class. Groups were led by a physiotherapist employed by the Multiple Sclerosis Society who received training to ensure a standard approach to intervention, intensity, and progression.",fulltext,"The group program was conducted at a local community center and included four to six participants per class. Groups were led by a physiotherapist employed by the Multiple Sclerosis Society who received training to ensure a standard approach to intervention, intensity, and progression.",100.0
697,PRECIS-2,"Exercises were aimed at improving gait speed, endurance, and balance. They were individualized, specific, progressed in load, and performed at a moderate to high intensity.",fulltext,"Exercises were aimed at improving gait speed, endurance, and balance. They were individualized, specific, progressed in load, and performed at a moderate to high intensity.",100.0
697,PRECIS-2,The primary outcome was gait speed (10-meter walk test).,fulltext,The primary outcome was gait speed (10-meter walk test).,100.0
697,PRECIS-2,"Eligible participants were excluded from the study if they were already engaged in a formal exercise program lasting >30 minutes twice per week, experienced an exacerbation within the past 4 weeks, had their MS immunomodulation medications altered in the previous 4 weeks or during the trial period, or declined to be randomly allocated.",fulltext,"Eligible participants were excluded from the study if they were already engaged in a formal exercise program lasting >30 minutes twice per week, experienced an exacerbation within the past 4 weeks, had their MS immunomodulation medications altered in the previous 4 weeks or during the trial period, or declined to be randomly allocated.",100.0
697,PRECIS-2,"Participants attended a local community center to complete all assessments at pre-intervention (week 0), post-intervention (week 8), and at follow-up (week 16).",fulltext,"Participants attended a local community center to complete all assessments at pre-intervention (week 0), post-intervention (week 8), and at follow-up (week 16).",100.0
697,PRECIS-2,"Home exercise participants were provided with one center-based physiotherapist-led session at the commencement of the intervention period for training, and telephone support by a physiotherapist to discuss their program every 2 weeks.",fulltext,"Home exercise participants were provided with one center-based physiotherapist-led session at the commencement of the intervention period for training, and telephone support by a physiotherapist to discuss their program every 2 weeks.",100.0
697,PRECIS-2,Data were analyzed according to the intention-to-treat principle.,fulltext,Data were analyzed according to the intention-to-treat principle.,100.0
697,PRECIS-2,"Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other neurological or orthopedic condition that would affect their function.",fulltext,"Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other neurological or orthopedic condition that would affect their function.",100.0
697,PRECIS-2,"The exercise program for both groups included two, 60-minute sessions per week, held at least 2 days apart for 8 weeks.",fulltext,"The exercise program for both groups included two, 60-minute sessions per week, held at least 2 days apart for 8 weeks.",100.0
697,PRECIS-2,Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.,fulltext,Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.,100.0
705,PRECIS-2,"The intervention group also demonstrated greater improvements in other clinical measures, physical activity, diet, and self-rated health at 12 wk; most sustained to 12 months.",fulltext,"The intervention group also demonstrated greater improvements in other clinical measures, physical activity, diet, and self-rated health at 12 wk; most sustained to 12 months.",100.0
705,PRECIS-2,Recruitment of 80 eligible participants was completed in a short time frame using methods that were easy to implement and with no added costs.,fulltext,Recruitment of 80 eligible participants was completed in a short time frame using methods that were easy to implement and with no added costs.,100.0
705,PRECIS-2,"Across both sites, the most successful methods of recruitment included communication from the hockey team via e-mail or social media (e.g., Twitter) and word of mouth, where 40% and 36% of men were recruited, respectively.",fulltext,"Across both sites, the most successful methods of recruitment included communication from the hockey team via e-mail or social media (e.g., Twitter) and word of mouth, where 40% and 36% of men were recruited, respectively.",100.0
705,PRECIS-2,"Furthermore, men were able to maintain most of these outcomes 12 months later, after a minimally supported phase, showing promise for long-term sustainability.",fulltext,"Furthermore, men were able to maintain most of these outcomes 12 months later, after a minimally supported phase, showing promise for long-term sustainability.",100.0
705,PRECIS-2,"The Hockey FIT program was delivered over 12 weekly, 90-min sessions by Hockey FIT coaches (coach to participant ratio 2:20) from the central research team.",fulltext,"The Hockey FIT program was delivered over 12 weekly, 90-min sessions by Hockey FIT coaches (coach to participant ratio 2:20) from the central research team.",100.0
705,PRECIS-2,"At the start of the program, more time was allocated to classroom education, but as the program progressed, more time was spent on group-based exercise.",fulltext,"At the start of the program, more time was allocated to classroom education, but as the program progressed, more time was spent on group-based exercise.",100.0
705,PRECIS-2,We ran an additional linear mixed-effects model within the intervention group only to obtain exploratory estimates for mean change from baseline to 12 months.,fulltext,We ran an additional linear mixed-effects model within the intervention group only to obtain exploratory estimates for mean change from baseline to 12 months.,100.0
705,PRECIS-2,"Trial retention was high at 12 wk (in both groups) and 12 months (intervention group only), and only one individual stated that he withdrew due to trial procedures (i.e., randomization).",fulltext,"Trial retention was high at 12 wk (in both groups) and 12 months (intervention group only), and only one individual stated that he withdrew due to trial procedures (i.e., randomization).",100.0
705,PRECIS-2,"We conducted a pilot, pragmatic randomized controlled trial (pRCT; parallel groups, stratified by site) in Ontario, Canada.",fulltext,"We conducted a pilot, pragmatic randomized controlled trial (pRCT; parallel groups, stratified by site) in Ontario, Canada.",100.0
705,PRECIS-2,"Our results are provocative because we found that men who participated in the Hockey FIT program lost weight, increased their steps per day, and improved other clinical outcomes (e.g., systolic BP), their diet, and perceptions of their own health, to a greater extent compared with the controls.",fulltext,"Our results are provocative because we found that men who participated in the Hockey FIT program lost weight, increased their steps per day, and improved other clinical outcomes (e.g., systolic BP), their diet, and perceptions of their own health, to a greater extent compared with the controls.",100.0
705,PRECIS-2,"Between 12 wk and 12 months (intervention group only), two individuals who had not attended the 12-wk measurement sessions returned to complete the 12-month measurement sessions and an additional five individuals were lost to follow-up.",fulltext,"Between 12 wk and 12 months (intervention group only), two individuals who had not attended the 12-wk measurement sessions returned to complete the 12-month measurement sessions and an additional five individuals were lost to follow-up.",100.0
705,PRECIS-2,"For the remaining 30 men (i.e., program completers), the mean (SD) for percentage of sessions attended was 81.7% (13.7).",fulltext,"For the remaining 30 men (i.e., program completers), the mean (SD) for percentage of sessions attended was 81.7% (13.7).",100.0
705,PRECIS-2,"We analyzed the data using likelihood-based methods, which are well known to provide unbiased results under the more general assumption of missing at random.",fulltext,"We analyzed the data using likelihood-based methods, which are well known to provide unbiased results under the more general assumption of missing at random.",100.0
705,PRECIS-2,"Although this study was designed as a pilot trial, we achieved many statistically and clinically important differences between groups at 12 wk, favoring the Hockey FIT group.",fulltext,"Although this study was designed as a pilot trial, we achieved many statistically and clinically important differences between groups at 12 wk, favoring the Hockey FIT group.",100.0
705,PRECIS-2,"Twice throughout the program, participants completed the validated Step Test and Exercise Prescription to receive a personalized target heart rate to strive for during aerobic activities.",fulltext,"Twice throughout the program, participants completed the validated Step Test and Exercise Prescription to receive a personalized target heart rate to strive for during aerobic activities.",100.0
705,PRECIS-2,"At 12 wk, the intervention group lost 3.6 kg (95% confidence interval, −5.26 to −1.90 kg) more than the comparator group (P < 0.001) and maintained this weight loss to 12 months.",fulltext,"At 12 wk, the intervention group lost 3.6 kg (95% confidence interval, −5.26 to −1.90 kg) more than the comparator group (P < 0.001) and maintained this weight loss to 12 months.",100.0
705,PRECIS-2,"Eligible participants were male 35–65 yr old with a BMI of ≥28 kg·m−2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).",fulltext,"Eligible participants were male 35–65 yr old with a BMI of ≥28 kg·m−2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).",100.0
705,PRECIS-2,"We used a pragmatic approach for the program venue at each site, using a combination of the hockey team’s arena and an affiliated health club facility.",fulltext,"We used a pragmatic approach for the program venue at each site, using a combination of the hockey team’s arena and an affiliated health club facility.",100.0
705,PRECIS-2,Male fans of two ice hockey teams (35–65 yr; body mass index ≥28 kg·m−2) located in Ontario (Canada) were randomized to intervention (Hockey FIT) or comparator (wait-list control).,fulltext,Male fans of two ice hockey teams (35–65 yr; body mass index ≥28 kg·m−2) located in Ontario (Canada) were randomized to intervention (Hockey FIT) or comparator (wait-list control).,100.0
705,PRECIS-2,We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach.,fulltext,We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach.,100.0
705,PRECIS-2,Participants were encouraged to continue with their lifestyle prescriptions and sustain their behavior changes with the support of free-of-charge eHealth tools.,fulltext,Participants were encouraged to continue with their lifestyle prescriptions and sustain their behavior changes with the support of free-of-charge eHealth tools.,100.0
705,PRECIS-2,"Participants were encouraged to continue with their lifestyle prescriptions and sustain their behavior changes with the support of free-of-charge eHealth tools: 1) HealtheSteps smartphone app providing tools to track and sustain PA (www.healthesteps.ca) and 2) Hockey FIT social network, a secure Web-based network tailored to each site and including only group members and coaches.",fulltext,"Participants were encouraged to continue with their lifestyle prescriptions and sustain their behavior changes with the support of free-of-charge eHealth tools: 1) HealtheSteps smartphone app providing tools to track and sustain PA (www.healthesteps.ca) and 2) Hockey FIT social network, a secure Web-based network tailored to each site and including only group members and coaches.",100.0
705,PRECIS-2,"In this study, we sought to reflect real-world conditions, in preparation for the definitive trial, where our goal will be to determine the effect of this program under conditions we expect it to be applied after research.",fulltext,"In this study, we sought to reflect real-world conditions, in preparation for the definitive trial, where our goal will be to determine the effect of this program under conditions we expect it to be applied after research.",100.0
712,PRECIS-2,"The pregnant women were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.",fulltext,"The pregnant women were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.",100.0
712,PRECIS-2,"We selected 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes.",fulltext,"We selected 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes.",100.0
712,PRECIS-2,"Those with the following were excluded: serious preeclampsia, placenta previa, immediate indication of cesarean, dilations at ≥ 8 cm and those that used analgesics for less than six hours from the study admission time.",fulltext,"Those with the following were excluded: serious preeclampsia, placenta previa, immediate indication of cesarean, dilations at ≥ 8 cm and those that used analgesics for less than six hours from the study admission time.",100.0
712,PRECIS-2,"The results show that the use of acupressure on the SP6 point is a complementary method that is non-invasive and can alleviate pain during childbirth, without presenting any adverse effects for pregnant women in labor and neonate women.",fulltext,"The results show that the use of acupressure on the SP6 point is a complementary method that is non-invasive and can alleviate pain during childbirth, without presenting any adverse effects for pregnant women in labor and neonate women.",100.0
712,PRECIS-2,The pregnant women in labor where encouraged during the CB to breath in and out deeply in the direction of the thorax during the contractions and the intervals in orde for their bodies to be totally relaxed (slow thorax-abdomen breathing rhythm).,fulltext,The pregnant women in labor where encouraged during the CB to breath in and out deeply in the direction of the thorax during the contractions and the intervals in orde for their bodies to be totally relaxed (slow thorax-abdomen breathing rhythm).,100.0
712,PRECIS-2,The study used the single-blind method (participants in the SP6 and TG groups did not know what group they were in).,fulltext,The study used the single-blind method (participants in the SP6 and TG groups did not know what group they were in).,100.0
712,PRECIS-2,The size of the sample was estimated through considering the proposed calculation method for the non-paired 14 t test.,fulltext,The size of the sample was estimated through considering the proposed calculation method for the non-paired 14 t test.,100.0
712,PRECIS-2,The researcher that was responsible for applying the acupressure went through 32 hours' worth of training.,fulltext,The researcher that was responsible for applying the acupressure went through 32 hours' worth of training.,100.0
712,PRECIS-2,"The pregnant women in labor obtained normal obstetrical treatment. Where the study was carried out, the following was permitted: the presence of someone to accompany the pregnant lady, the use of methods other than drugs such as taking a shower, massages in the lower back region and breathing exercises as well as liberty of movement (in cases where this did not go against medical advice).",fulltext,"The pregnant women in labor obtained normal obstetrical treatment. Where the study was carried out, the following was permitted: the presence of someone to accompany the pregnant lady, the use of methods other than drugs such as taking a shower, massages in the lower back region and breathing exercises as well as liberty of movement (in cases where this did not go against medical advice).",100.0
712,PRECIS-2,VAS was used to evaluate the pain and for pre-developed questions. The women were able to classify their perception of the pain.,fulltext,VAS was used to evaluate the pain and for pre-developed questions. The women were able to classify their perception of the pain.,100.0
712,PRECIS-2,"There were statistical differences (p<0.0001, Fridman test) in the VAS values for each group for the three times when the evaluations were done.",fulltext,"There were statistical differences (p<0.0001, Fridman test) in the VAS values for each group for the three times when the evaluations were done.",100.0
712,PRECIS-2,"We undertook a controlled and randomized clinical test (based on the consort diagram) employing the use of pragmatism. It was carried out between January and August of 2013. The subjects were pregnant women admitted to a teaching tertiary public hospital on the outskirts of the state of Sao Paulo, Brazil.",fulltext,"We undertook a controlled and randomized clinical test (based on the consort diagram) employing the use of pragmatism. It was carried out between January and August of 2013. The subjects were pregnant women admitted to a teaching tertiary public hospital on the outskirts of the state of Sao Paulo, Brazil.",100.0
712,PRECIS-2,The SP6 group with the pregnant women in labor received deep pressure (± 5kg) with fast decompression applied to their thumbs which did not bring about any discomfort.,fulltext,The SP6 group with the pregnant women in labor received deep pressure (± 5kg) with fast decompression applied to their thumbs which did not bring about any discomfort.,100.0
713,PRECIS-2,"Of those, 58% (14/24) participated in the smoking cessation treatment.",fulltext,"Of those, 58% (14/24) participated in the smoking cessation treatment.",100.0
713,PRECIS-2,"The theoretical framework, Partnership with people with COPD and their families, was the basis for this intervention. It was adjusted to the particular needs of young people with COPD in its early stages.",fulltext," The theoretical framework, Partnership with people with COPD and their families (Ingadottir & Jonsdottir 2010, Jonsdottir & Ingadottir 2011a,b), was the basis for this intervention. It was adjusted to the particular needs of young people with COPD in its early stages",99.50980392156863
713,PRECIS-2,"Data were collected at baseline and at month 12. Additionally, data collection was carried out in the experimental group at month 6 after the last treatment session.",fulltext,"Data were collected at baseline and at month 12. Additionally, data collection was carried out in the experimental group at month 6 after the last treatment session.",100.0
713,PRECIS-2,"Excluded were individuals who had another major disease (among them individuals with asthma who had more than 200 ml or 12% increase in FEV1 after inhalation of 200 μg albuterol in the post-bronchodilator spirometry), who were non-Icelandic speaking, not capable of travelling to the treatment site and those who had participated in a structured rehabilitation programme for people with COPD 6 months prior to the screening.",fulltext,"Excluded were individuals who had another major disease (among them individuals with asthma who had more than 200 ml or 12% increase in FEV1 after inhalation of 200 μg albuterol in the post-bronchodilator spirometry), who were non-Icelandic speaking, not capable of travelling to the treatment site and those who had participated in a structured rehabilitation programme for people with COPD 6 months prior to the screening.",100.0
713,PRECIS-2,The treatment site was a clinical research centre located on a university-hospital campus.,fulltext,The treatment site was a clinical research centre located on a university-hospital campus.,100.0
713,PRECIS-2,"The 6-month partnership-based self-management programme had benefits on the perception of the intrusiveness of chronic obstructive pulmonary disease and its treatment on lifestyles, activities and interests for young patients with the disease in its early stages.",fulltext,"The 6-month partnership-based self-management programme had benefits on the perception of the intrusiveness of chronic obstructive pulmonary disease and its treatment as regards lifestyles, activities and interests for young patients with the disease in its early stages.",99.23954372623575
713,PRECIS-2,Intention-to-treat analysis was not carried out.,fulltext,Intention-to-treat analysis was not carried out.,100.0
713,PRECIS-2,"There were 119 patients who started participation, with 100 completing the study.",fulltext,"There were 119 patients who started participation, with 100 completing the study.",100.0
713,PRECIS-2,All potentially relevant patients (n = 291) were contacted for enrolment in the study from primary healthcare settings (n = 8) and the offices of private lung physicians (n = 6) in the Reykjavik capital area of Iceland.,fulltext,All potentially relevant patients (n = 291) were contacted for enrolment in the study from primary healthcare settings (n = 8) and the offices of private lung physicians (n = 6) in the Reykjavik capital area of Iceland.,100.0
713,PRECIS-2,The intervention was an addition to traditional health care which the control group received. Traditional health care refers to services provided by general practitioners at primary health care centres and visits to lung physicians based on referral from general practitioners or self-initiated appointments.,fulltext,The intervention was an addition to traditional health care which the control group received. Traditional health care refers to services provided by general practitioners at primary health care centres and visits to lung physicians based on referral from general practitioners or self-initiated appointments.,100.0
714,PRECIS-2,From their computerised asthma registers the practices identified adults (⩾18 years) who had asked for a bronchodilator inhaler prescription in the previous six months but who had not had a routine asthma review in the preceding 11 months.,fulltext,From their computerised asthma registers the practices identified adults (⩾18 years) who had asked for a bronchodilator inhaler prescription in the previous six months but who had not had a routine asthma review in the preceding 11 months.,100.0
714,PRECIS-2,"Patients were excluded if the diagnosis of asthma had been made within the previous year, if they had chronic obstructive pulmonary disease, if communication difficulties made a telephone consultation impossible, or (at the general practitioner's request) for major social or medical reasons.",fulltext,"Patients were excluded if the diagnosis of asthma had been made within the previous year, if they had chronic obstructive pulmonary disease, if communication difficulties made a telephone consultation impossible, or (at the general practitioner's request) for major social or medical reasons.",100.0
714,PRECIS-2,"Our practices were all “asthma interested”—they all had specialist nurses with considerable experience of providing asthma care, potentially enhancing their skills to undertake telephone consultations.",fulltext,"Our practices were all “asthma interested”—they all had specialist nurses with considerable experience of providing asthma care, potentially enhancing their skills to undertake telephone consultations.",100.0
714,PRECIS-2,Follow up questionnaires on morbidity and satisfaction with the consultation were sent to the patients at three months.,fulltext,Follow up questionnaires on morbidity and satisfaction with the consultation were sent to the patients at three months.,100.0
714,PRECIS-2,Patients were sent a letter from their practice informing them that they had been allocated to receive a telephone review and that they should expect a call from the asthma nurse within a month.,fulltext, were sent a letter from their practice informing them that they had been allocated to receive a telephone review and that they should expect a call from the asthma nurse within a month.,95.87628865979381
714,PRECIS-2,Nurses were told to make up to four attempts to contact the patient by phone.,fulltext,Nurses were told to make up to four attempts to contact the patient by phone.,100.0
714,PRECIS-2,Nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient's clinical need.,fulltext,Nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient's clinical need.,100.0
714,PRECIS-2,"Primary outcome measures were the proportion of patients reviewed within three months of randomisation and change in asthma related quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",fulltext,"Primary outcome measures were the proportion of patients reviewed within three months of randomisation and change in asthma related quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",100.0
714,PRECIS-2,Four general practices in England.,fulltext,Four general practices in England.,100.0
714,PRECIS-2,Our participants were slightly older than the total eligible population and may not be wholly representative of all adults with asthma in these practices.,fulltext,Our participants were slightly older than the total eligible population and may not be wholly representative of all adults with asthma in these practices.,100.0
714,PRECIS-2,Telephone consultations are safe alternatives in the triage of requests for same day appointments and out of hours care.,fulltext,Telephone consultations are safe alternatives in the triage of requests for same day appointments and out of hours care.,100.0
714,PRECIS-2,"Our study aimed to reflect, as far as possible, normal care of patients with asthma in the participating practices. We asked nurses not to change their clinical practice.",fulltext,"Our study aimed to reflect, as far as possible, normal care of patients with asthma in the participating practices. We asked nurses not to change their clinical practice.",100.0
714,PRECIS-2,"On an intention to treat analysis, 101 of the 137 patients (74%) allocated to the telephone arm were reviewed, compared with 68 of the 141 patients (48%) in the face to face consultation arm.",fulltext,"On an intention to treat analysis, 101 of the 137 patients (74%) allocated to the telephone arm were reviewed, compared with 68 of the 141 patients (48%) in the face to face consultation arm.",100.0
715,PRECIS-2,NLC has lower consultation costs.,fulltext,NLC has lower consultation costs.,100.0
715,PRECIS-2,"The NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays.",fulltext,"The NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays.",100.0
715,PRECIS-2,Analysis followed per-protocol (PP) and intention-to-treat (ITT) approaches.,fulltext,Analysis followed per-protocol (PP) and intention-to-treat (ITT) approaches.,100.0
715,PRECIS-2,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria),29 age 18 years or older and the ability to complete questionnaires unaided. Exclusions were: unstabilised concomitant disease, awaiting surgery and already receiving care from the practitioners involved in the study.",fulltext,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria),29 age 18 years or older and the ability to complete questionnaires unaided. Exclusions were: unstabilised concomitant disease, awaiting surgery and already receiving care from the practitioners involved in the study.",100.0
715,PRECIS-2,The study was conducted in outpatient clinics of 10 rheumatology centres across the UK.,fulltext,The study was conducted in outpatient clinics of 10 rheumatology centres across the UK.,100.0
715,PRECIS-2,"The primary outcome was the disease activity score (DAS28) assessed at baseline, weeks 13, 26, 39 and 52; the non-inferiority margin being DAS28 change of 0.6.",fulltext,"The primary outcome was the disease activity score (DAS28) assessed at baseline, weeks 13, 26, 39 and 52; the non-inferiority margin being DAS28 change of 0.6.",100.0
715,PRECIS-2,"This study required three practitioners at each centre; a CNS, a rheumatologist and a blind independent assessor. Nine CNS and 10 rheumatologists delivered the interventions. The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level.",fulltext,"This study required three practitioners at each centre; a CNS, a rheumatologist and a blind independent assessor. Nine CNS and 10 rheumatologists delivered the interventions. The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level.",100.0
715,PRECIS-2,"Patients were seen by their respective practitioners at baseline and at weeks 13, 26, 39 and 52.",fulltext,"Patients were seen by their respective practitioners at baseline and at weeks 13, 26, 39 and 52.",100.0
722,PRECIS-2,Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter.,fulltext,Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter.,100.0
722,PRECIS-2,All participants were treated by their regular doctor following randomization.,fulltext,All participants were treated by their regular doctor following randomization.,100.0
722,PRECIS-2,"Men and women aged ≥18 years at high CVD risk, defined as either established CVD (history of coronary, ischaemic cerebrovascular, or peripheral vascular disease) or an estimated five-year CVD risk of ≥15% (using the Framingham risk equation, including a 5% increment for Aboriginal or Torres Strait Islander identification)21 were eligible.",fulltext,"Men and women aged ≥18 years at high CVD risk, defined as either established CVD (history of coronary, ischaemic cerebrovascular, or peripheral vascular disease) or an estimated five-year CVD risk of ≥15% (using the Framingham risk equation, including a 5% increment for Aboriginal or Torres Strait Islander identification)21 were eligible.",100.0
722,PRECIS-2,"The Kanyini GAP trial was designed to be highly pragmatic with the prescribing, dispensing and payment for polypill occurring identically to what would be usual care, if the polypill were to be marketed in Australia and subsidized through the Pharmaceutical Benefits Scheme.",fulltext,"The Kanyini GAP trial was designed to be highly pragmatic with the prescribing, dispensing and payment for polypill occurring identically to what would be usual care, if the polypill were to be marketed in Australia and subsidized through the Pharmaceutical Benefits Scheme.",100.0
722,PRECIS-2,All analyses were conducted on an intention-to-treat basis without imputation of missing data.,fulltext,All analyses were conducted on an intention-to-treat basis without imputation of missing data.,100.0
722,PRECIS-2,"The adherence outcome was a composite of adherence to all three treatment modalities, but there were smaller adherence improvements for each individual treatment modality.",fulltext,"The adherence outcome was a composite of adherence to all three treatment modalities, but there were smaller adherence improvements for each individual treatment modality.",100.0
722,PRECIS-2,"Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and ≥2 BP lowering therapies for ≥4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.",fulltext,"Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and ≥2 BP lowering therapies for ≥4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.",100.0
722,PRECIS-2,Participants were excluded if it was felt clinically inappropriate to alter medications.,fulltext,Participants were excluded if it was felt clinically inappropriate to alter medications.,100.0
722,PRECIS-2,"No attempt was made to influence any other aspect of their management. The doctor could, at any time, change prescription to the alternative polypill version, add drugs on top of the polypill, or withdraw the polypill and substitute individual drugs of their choice.",fulltext,"No attempt was made to influence any other aspect of their management. The doctor could, at any time, change prescription to the alternative polypill version, add drugs on top of the polypill, or withdraw the polypill and substitute individual drugs of their choice.",100.0
725,PRECIS-2,"It was emphasized that good standards of care, both surgical and nonsurgical, should be provided throughout the treatment pathway for the injury, including surgical care or management of the sling, postoperative care, and rehabilitation in both groups.",fulltext,"It was emphasized that good standards of care, both surgical and nonsurgical, should be provided throughout the treatment pathway for the injury, including surgical care or management of the sling, postoperative care, and rehabilitation in both groups.",100.0
725,PRECIS-2,"The primary outcome was the Oxford Shoulder Score (range, 0-48; higher scores indicate better outcomes) assessed during a 2-year period, with assessment and data collection at 6, 12, and 24 months.",fulltext," Primary outcome was the Oxford Shoulder Score (range, 0-48; higher scores indicate better outcomes) assessed during a 2-year period, with assessment and data collection at 6, 12, and 24 months.",98.47715736040608
725,PRECIS-2,Patients were followed up for 2 years (up to April 2013) and 215 had complete follow-up data.,fulltext,Patients were followed up for 2 years (up to April 2013) and 215 had complete follow-up data.,100.0
725,PRECIS-2,"The PROFHER collaborators recruited patients for this pragmatic, open, multicenter, parallel-group, superiority, randomized clinical trial between September 2008 and April 2011 from orthopedic departments (fracture clinics or wards) at 32 acute UK National Health Service hospitals.",fulltext,"The PROFHER collaborators recruited patients for this pragmatic, open, multicenter, parallel-group, superiority, randomized clinical trial between September 2008 and April 2011 from orthopedic departments (fracture clinics or wards) at 32 acute UK National Health Service hospitals.",100.0
725,PRECIS-2,Participating hospitals did not introduce new or experimental interventions for these fractures during the study.,fulltext,Participating hospitals did not introduce new or experimental interventions for these fractures during the study.,100.0
725,PRECIS-2,"Analyses followed a prespecified analysis plan, endorsed by the data monitoring and ethics committee, and were performed using Stata version 12 (StataCorp). All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized.",fulltext,"Analyses followed a prespecified analysis plan, endorsed by the data monitoring and ethics committee, and were performed using Stata version 12 (StataCorp). All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized.",100.0
733,PRECIS-2,"The interventions were the home-based Otago Exercise Programme (OEP), and a group-based exercise programme called Falls Management Exercise (FaME).",fulltext,"The interventions were the home-based Otago Exercise Programme (OEP),10 and a group-based exercise programme called Falls Management Exercise (FaME).",100.0
733,PRECIS-2,"Volunteer peer mentors supported participants in the OEP arm, and weekly FaME classes were run in local venues by postural stability instructors trained to work with older people.",fulltext,"Volunteer peer mentors supported participants in the OEP arm, and weekly FaME classes were run in local venues by postural stability instructors trained to work with older people.",100.0
733,PRECIS-2,"Pragmatic three-arm, parallel-design cluster randomised controlled trial involving 1256 people aged ≥65 years (of 20 507 invited) recruited from 43 general practices in London, Nottingham, and Derby.",fulltext,"Pragmatic three-arm, parallel-design cluster randomised controlled trial involving 1256 people aged ≥65 years (of 20 507 invited) recruited from 43 general practices in London, Nottingham, and Derby.",100.0
733,PRECIS-2,The primary outcome was the proportion of participants who reported reaching ≥150 minutes of MVPA per week.,fulltext,The primary outcome was the proportion of participants who reported reaching ≥150 minutes of MVPA per week.,100.0
733,PRECIS-2,"Participants were analysed in the groups to which they were randomised, regardless of whether they received the intervention or not, and multiple imputation was used to include all participants in the analyses.",fulltext,"Participants were analysed in the groups to which they were randomised, regardless of whether they received the intervention or not, and multiple imputation was used to include all participants in the analyses.",100.0
733,PRECIS-2,"Adherence was defined as (minutes spent exercising/intended minutes) 100%, where patients with values exceeding 75% were regarded as ‘adherent’.",fulltext,"Adherence was defined as (minutes spent exercising/intended minutes) 100%, where patients with values exceeding 75% were regarded as ‘adherent’.",100.0
733,PRECIS-2,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham. Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP.",fulltext,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham. Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP.",100.0
733,PRECIS-2,"The programmes included the following progression: OEP — ankle weights and hand holds; and FaME — resistance bands and hand holds, plus a move to more dynamic balance work and floor work with postural stability instructors.",fulltext,"The programmes included the following progression: OEP — ankle weights and hand holds; and FaME — resistance bands and hand holds, plus a move to more dynamic balance work and floor work with postural stability instructors.",100.0
733,PRECIS-2,Patients were excluded if they: had experienced ≥3 falls in the previous year; had unstable clinical conditions; would be unable to follow instructions about exercise safely; or were receiving palliative care.,fulltext,Patients were excluded if they: had experienced ≥3 falls in the previous year; had unstable clinical conditions; would be unable to follow instructions about exercise safely; or were receiving palliative care.,100.0
733,PRECIS-2,Patients were eligible to participate if they were: community dwelling aged ≥65 years; independently mobile (with or without a walking aid); and physically able to take part in group exercise.,fulltext,Patients were eligible to participate if they were: community dwelling aged ≥65 years; independently mobile (with or without a walking aid); and physically able to take part in group exercise.,100.0
733,PRECIS-2,"Participants were followed up every 6 months after the end of the intervention period, until 24 months.",fulltext,"Participants were followed up every 6 months after the end of the intervention period, until 24 months.",100.0
